National surveillance reports estimate that there were about 649 persons living with HIV in St. Vincent and the Grenadines at the end of 2011, which translates to 1.2% of the adult population (15-49 years) or 0.7% of the total population. The epidemic is male-dominant, illustrated by the fact that the cumulative case reporting from 1984-2013 indicates that 60.6% of new cases are reported among males and 38.1% females (1.3% unknown). In response to the growing epidemic, the country quickly scaled up its national HIV/AIDS program in 2004. While care and treatment remains a high priority, St. Vincent and the Grenadines has devoted significant resources to preventative activities, including HIV counseling and rapid testing, education and workplace programs, and other behavioral interventions.
Despite a marked decline in HIV and AIDS cases, significant challenges for the country’s response remain. Close to 20% of persons with advanced HIV infection discontinue treatment within 12 months of initiation, suggesting the need to reinforce adherence and retention to care. The country also faces an imminent decline in donor funding and domestic reprioritization of chronic and non-communicable diseases; without renewed sources of external funding or greater domestic resources allocated to HIV/AIDS, progress made since 2004 could regress.
In response to these challenges, key priorities outlined in the country’s strategic framework (2014-2025) include: 1) institutionalizing HIV education through collaborative programs with different sectors, 2) targeting high risk groups, 3) strengthening HIV testing and counseling, including routine testing for pregnant women and, 4) ensuring access and retention to care and treatment for those with HIV and AIDS and TB. St. Vincent and the Grenadines has also taken steps to integrate HIV and AIDS services into the broader health system and included the HIV and AIDS program as part of the Ministry of Health, Environment and Wellness’ overall health framework. These actions are the beginning of efforts to improve access to care, reduce costs, and improve efficiencies.
Sustaining the HIV and AIDS Response in the Countries of the OECS: Regional I...HFG Project
In 2014, the six countries of the Organization of Eastern Caribbean States (OECS) of Antigua and Barbuda, Dominica, Grenada, St. Kitts and Nevis, St. Lucia and St. Vincent and the Grenadines developed HIV and AIDS Investment Case Briefs, with the support of USAID’s Health Finance and Governance (HFG) and Strengthening Health Outcomes through the Private Sector (SHOPS) projects. This document provides a summary of the findings of these briefs, which includes an analysis of the costs of HIV and AIDS programs that respond to the disease in the six countries, the resources that are available, the funding gaps, and the potential impact of different levels of investment in programming on the progression of the disease in the region.
Fighting Health Security Threats Requires a Cross-Border ApproachHFG Project
This document discusses how health security threats like Ebola and Zika require a cross-border approach. It summarizes efforts taken in the Caribbean region to strengthen health security through regional cooperation. Key steps included conducting a regional self-assessment using Global Health Security Agenda tools, developing a Caribbean Region GHSA Roadmap with input from over 70 stakeholders, and reinvigorating the Regional Coordinating Mechanism for Health Security. The roadmap establishes targets and plans for 19 health security capacities across Caribbean countries and aims to improve regional communication, coordination, and cooperation to address health threats.
Integrating HIV/AIDS in Vietnam’s Social Health Insurance Scheme: Experience ...HFG Project
The document describes lessons learned from integrating HIV/AIDS services into Vietnam's social health insurance scheme from 2014-2017. It discusses challenges such as HIV services originally being provided through donor funding and separate from the insurance scheme. The Health Finance and Governance project worked with Vietnamese government agencies to address barriers through technical assistance. This included integrating HIV treatment facilities into the public system funded by insurance, expanding insurance coverage, and shifting to local drug procurement. The project aligned with government policies and created evidence to advocate for sustainable HIV financing as donors transitioned support. Major lessons were the importance of working within complex adaptive systems and existing policy frameworks.
Reaching the Missing Middle: Ensuring Health Coverage for India’s Urban PoorHFG Project
This document discusses health coverage challenges facing India's urban poor population and opportunities to expand coverage through the new National Health Protection Scheme (NHPS). It notes that India's urban poor, estimated at 27% of the urban population, have been excluded from existing public health insurance schemes that target those below the poverty line. The NHPS, announced in 2018, aims to provide health insurance of up to 500,000 rupees per family annually. The document argues that integrating primary health care benefits into insurance schemes could help manage population health and reduce costs by keeping people healthy and out of hospitals. There is no single solution, but the NHPS could play a major role in expanding safety nets for the urban poor through financial protection and investing in
Extending health insurance coverage to the informal sector: Lessons from a pr...HFG Project
As a growing number of low‐ and middle-income countries commit to achieving universal health coverage, one key challenge is how to extend coverage to informal sector workers. Micro health insurance (MHI) provides a potential model to finance health services for this population. This study presents lessons from a pilot study of a mandatory MHI plan offered by a private insurance company and distributed through a microfinance bank to urban, informal sector workers in Lagos, Nigeria.
Can community action improve equity for maternal health and how does it do soHFG Project
Efforts to work with civil society to strengthen community participation and action for health are particularly important in Gujarat, India, given that the state has resources and capacity, but faces challenges in ensuring that services reach those most in need. To contribute to the knowledge base on accountability and maternal health, this study examines the equity effects of community action for maternal health led by Non-Government Organizations (NGOs) on facility deliveries. It then examines the underlying implementation processes with implications for strengthening accountability of maternity care across three districts of Gujarat, India. Community action for maternal health entailed NGOs a) working with community collectives to raise awareness about maternal health entitlements, b) supporting community monitoring of outreach government services, and c) facilitating dialogue with government providers and authorities with report cards based on community monitoring of maternal health.
The USAID Health Finance and Governance project, led by Abt Associates, works with developing countries to expand access to healthcare. It helps countries increase domestic health funding, manage resources effectively, and make wise purchasing decisions. The project provides technical assistance in over 40 countries on improving health financing, governance, management systems, and measuring universal health coverage progress.
The National HIV Prevention Inventory provides the first, comprehensive inventory of HIV prevention efforts at the state and local levels in the United States. Based on a survey of 65 health departments, including all state and territorial jurisdictions and six U.S. cities, the Inventory is intended to offer a baseline picture of how HIV prevention is delivered across the country in an effort to provide policymakers, public health officials, community organizations, and others with a more in depth understanding of HIV prevention and the role played by health departments in its delivery.
Sustaining the HIV and AIDS Response in the Countries of the OECS: Regional I...HFG Project
In 2014, the six countries of the Organization of Eastern Caribbean States (OECS) of Antigua and Barbuda, Dominica, Grenada, St. Kitts and Nevis, St. Lucia and St. Vincent and the Grenadines developed HIV and AIDS Investment Case Briefs, with the support of USAID’s Health Finance and Governance (HFG) and Strengthening Health Outcomes through the Private Sector (SHOPS) projects. This document provides a summary of the findings of these briefs, which includes an analysis of the costs of HIV and AIDS programs that respond to the disease in the six countries, the resources that are available, the funding gaps, and the potential impact of different levels of investment in programming on the progression of the disease in the region.
Fighting Health Security Threats Requires a Cross-Border ApproachHFG Project
This document discusses how health security threats like Ebola and Zika require a cross-border approach. It summarizes efforts taken in the Caribbean region to strengthen health security through regional cooperation. Key steps included conducting a regional self-assessment using Global Health Security Agenda tools, developing a Caribbean Region GHSA Roadmap with input from over 70 stakeholders, and reinvigorating the Regional Coordinating Mechanism for Health Security. The roadmap establishes targets and plans for 19 health security capacities across Caribbean countries and aims to improve regional communication, coordination, and cooperation to address health threats.
Integrating HIV/AIDS in Vietnam’s Social Health Insurance Scheme: Experience ...HFG Project
The document describes lessons learned from integrating HIV/AIDS services into Vietnam's social health insurance scheme from 2014-2017. It discusses challenges such as HIV services originally being provided through donor funding and separate from the insurance scheme. The Health Finance and Governance project worked with Vietnamese government agencies to address barriers through technical assistance. This included integrating HIV treatment facilities into the public system funded by insurance, expanding insurance coverage, and shifting to local drug procurement. The project aligned with government policies and created evidence to advocate for sustainable HIV financing as donors transitioned support. Major lessons were the importance of working within complex adaptive systems and existing policy frameworks.
Reaching the Missing Middle: Ensuring Health Coverage for India’s Urban PoorHFG Project
This document discusses health coverage challenges facing India's urban poor population and opportunities to expand coverage through the new National Health Protection Scheme (NHPS). It notes that India's urban poor, estimated at 27% of the urban population, have been excluded from existing public health insurance schemes that target those below the poverty line. The NHPS, announced in 2018, aims to provide health insurance of up to 500,000 rupees per family annually. The document argues that integrating primary health care benefits into insurance schemes could help manage population health and reduce costs by keeping people healthy and out of hospitals. There is no single solution, but the NHPS could play a major role in expanding safety nets for the urban poor through financial protection and investing in
Extending health insurance coverage to the informal sector: Lessons from a pr...HFG Project
As a growing number of low‐ and middle-income countries commit to achieving universal health coverage, one key challenge is how to extend coverage to informal sector workers. Micro health insurance (MHI) provides a potential model to finance health services for this population. This study presents lessons from a pilot study of a mandatory MHI plan offered by a private insurance company and distributed through a microfinance bank to urban, informal sector workers in Lagos, Nigeria.
Can community action improve equity for maternal health and how does it do soHFG Project
Efforts to work with civil society to strengthen community participation and action for health are particularly important in Gujarat, India, given that the state has resources and capacity, but faces challenges in ensuring that services reach those most in need. To contribute to the knowledge base on accountability and maternal health, this study examines the equity effects of community action for maternal health led by Non-Government Organizations (NGOs) on facility deliveries. It then examines the underlying implementation processes with implications for strengthening accountability of maternity care across three districts of Gujarat, India. Community action for maternal health entailed NGOs a) working with community collectives to raise awareness about maternal health entitlements, b) supporting community monitoring of outreach government services, and c) facilitating dialogue with government providers and authorities with report cards based on community monitoring of maternal health.
The USAID Health Finance and Governance project, led by Abt Associates, works with developing countries to expand access to healthcare. It helps countries increase domestic health funding, manage resources effectively, and make wise purchasing decisions. The project provides technical assistance in over 40 countries on improving health financing, governance, management systems, and measuring universal health coverage progress.
The National HIV Prevention Inventory provides the first, comprehensive inventory of HIV prevention efforts at the state and local levels in the United States. Based on a survey of 65 health departments, including all state and territorial jurisdictions and six U.S. cities, the Inventory is intended to offer a baseline picture of how HIV prevention is delivered across the country in an effort to provide policymakers, public health officials, community organizations, and others with a more in depth understanding of HIV prevention and the role played by health departments in its delivery.
Trends in health financing and the private health sector in the middle east a...HFG Project
In the past several decades, countries in the Middle East and North Africa have made significant improvements in developing their health systems and improving the health status of their populations. However, the region continues to face substantial and diverse political, macroeconomic,social, and health challenges. In 2010–2011, the mass uprisings over high unemployment, poverty, and political repression known as the Arab Spring began in several countries. These events led to a wave of social and political upheaval that had enduring repercussions throughout the region. Iraq, Libya, Syria, and Yemen remain embroiled in prolonged violent conflicts. Other countries are more stable but undergoing significant changes and reforms.
To understand current health financing policies and mechanisms, as well as the current role of the private sector in the health systems of the Middle East, the USAID Middle East Regional Bureau commissioned the Sustaining Health Outcomes through the Private Sector (SHOPS) Plus and Health Finance and Governance (HFG) projects to conduct a review of health financing and the private health sector in the 11 low-and middle-income countries in the region, focusing on the years 2008 to 2017.1 The countries included in this analysis are Algeria, Egypt, Iraq, Jordan, Lebanon, Libya, Morocco, Syria, Tunisia, the West Bank and Gaza, and Yemen. This review aims to highlight regional trends and identify gaps in information.
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...HFG Project
The purpose of this report is to capture and consolidate the suggestions of the Sustainability Group for consideration by the Government of Dominican Republic (GODR) and other relevant stakeholders. GODR will be able to draw from this report when developing its HIV sustainability strategy, revising the National Strategic Plan for HIV (PEN), and developing other planning and policy documents.
HFG began working in Namibia in 2013, closely partnering with the Namibian Ministry of Health and Social Services and going on to collaborate with key government agencies, such as the Namibian Social Security Commission and the Universal Health
Coverage Advisory Committee of Namibia. The overarching aim of our technical assistance has been to support Namibia’s progress toward UHC to ensure all can access necessary, quality health care without financial struggle. We emphasized a government-led and -owned approach as we supported the Namibian government in addressing some of the key challenges it faced at the start of the project.
HFG’s support has helped strengthen the government’s capacity to mobilize and manage resources; improve efficiency, quality, and equity of health services; expand access to health care; sustain key health interventions, especially the HIV/AIDS prevention, care, and treatment program; and, ultimately, identify sustainable financing for UHC. We provided technical support to the Namibian government’s Health Accounts team, equipping them with tools and know-how to lead and implement four Health Accounts exercises and analyze and present data for better policy analysis and evidence-based decision making. Our support has helped institutionalize Health Accounts in Namibia and provided the country’s policymakers with evidence to examine health financing options for UHC, advocate for greater resources, and explore financial risk protection options.
Strengthening the larger health system and generating fiscal space through improved efficiency of health services was another important goal for HFG.
Findings of the health facility costing and district hospital efficiency study we undertook will enable the government to identify where it can save resources, how it can improve equity in service distribution, and what Namibia’s total financing requirement is for UHC.
This report highlights some of the major contributions HFG and its key partners have made toward more efficient use of limited health resources, improved sustainability of
health programs, and progress toward UHC in Namibia.
Monitoring progress towards universal health coverage at country and global l...The Rockefeller Foundation
A movement towards universal health coverage (UHC) – ensuring that everyone who needs health services is able to get them, without undue financial hardship – has been growing across the globe (1). This has led to a sharp increase in the demand for expertise, evidence and measures of progress and a push to make UHC one of the goals of the post-2015 development agenda (2). This paper proposes a framework for tracking country and global progress towards UHC; its aim is to inform and guide these discussions and assessment of both aggregate and equitable coverage of essential health services as well as financial protection. Monitoring progress towards these two components of UHC will be complementary and critical to achieving desirable health outcome goals, such as ending preventable deaths and promoting healthy life expectancy and also reducing poverty and protecting household incomes.
This paper was written jointly by the World Health Organization (WHO) and The World Bank Group on the basis of consultations and discussions with country representatives, technical experts and global health and development partners (3). A draft of this paper was posted online and circulated widely for consultation between December 2013 and February 2014. Nearly 70 submissions were received from countries, development partners, civil society, academics and other interested stakeholders. The feedback was synthesized and reviewed at a meeting of country and global experts in Bellagio, Italy, in March 2014 (4). The paper was modified to reflect the views emerging from these consultations.
1) The World Health Organization (WHO) report "Health for the world's adolescents" addresses improving health outcomes for the world's one billion adolescents. It highlights both successes, such as declining adolescent pregnancy and maternal mortality rates in some regions, as well as ongoing challenges like HIV mortality among adolescents rising in Africa.
2) Adolescence is a crucial life stage for establishing health behaviors and patterns that affect future adult health. Many major causes of illness and death among adolescents, like road injuries, violence, and mental health issues, have preventable underlying factors.
3) Achieving overall health and development requires a holistic, multisector approach that addresses individual, social, and environmental determinants of adolescent health
Preparing for future shocks: Building resilient health systemsHFG Project
Presentation at USAID's Global Health Mini-University on Friday, March 4, 2016.
Preparing for Future Shocks: Building Resilient Health Systems
Kate Greene (HFG), Bob Emrey (USAID/GH/OHS), Jodi Charles (USAID/GH/OHS), Temitayo Ifafore, (USAID/GH/OHS)
After the recent Ebola outbreak, global health experts have turned to resilience frameworks used by other fields such as agriculture and engineering to understand how to build health systems that can withstand shocks, including infectious disease outbreaks, natural disasters, and political conflict. Speakers will first briefly outline each of the five key elements of the Resilience Framework, adapted from the Rockefeller Foundation and presented in a Lancet article in 2015, that can be applied to health systems. Participants will then work in small groups to discuss which health systems interventions should be pursued in response to a one-page description of an unnamed country. Speakers will then reveal what real-world interventions they designed for the country example and answer questions.
The document analyzes alternatives for Haiti's government to provide HIV medication to its citizens. It discusses that Haiti currently has 120,000 people living with HIV but the government lacks resources to provide medication. The status quo alternative relies on NGOs like PSI to fund programs, but long-term stability is uncertain if NGOs withdraw support. A second alternative is passing an anti-discrimination law to reduce barriers patients face in accessing care. The document evaluates alternatives based on percentage of patients treated, cost-effectiveness, and feasibility of implementation in Haiti's unstable political environment.
The Health Finance and Governance Briefing KitHFG Project
Resource Type: Brief
Authors: Megan Meline, Lisa Tarantino, Jeremy Kanthor, and Sharon Nakhimovsky
Published: September 2015
Resource Description: Getting access to affordable, quality health care is a universal story that touches virtually every family in the world. At the same time, providing quality health services and access to trained health professionals is a challenge for governments. The World Health Organization (WHO) estimates that 150 million people worldwide face “catastrophic expenditure” because of high costs of health care. In other words, they may have to forgo paying for basic needs, such as food, housing, or education to pay for medical treatment instead. These costs include transportation, doctors’ fees, medicine, hospitalization bills, and days lost from work.
Behind these sobering statistics lies a wealth of news and feature stories waiting for the media to investigate and share with national leaders and policymakers as well as civil society groups who can advocate for changes to health budgets and policies. At the heart of these stories are important questions about the financing of health care and the quality of governance that ensures responsive and effective management of those resources and services.
But writing health finance and governance stories can be challenging. Health finance is riddled with complex language, technical economic terms, and numbers – not necessarily a journalist’s comfort zone. The right sources for these stories can be difficult to identify and unwilling to talk. Data may be difficult to locate or to understand. And while corruption makes for splashy headlines, the broader systemic challenges of health governance are not widely understood — and yet they are important.
The Health Finance and Governance Briefing Kit is designed to help journalists and their editors uncover and tell these important health stories that affect people all around the world.
Mobilizing Domestic Resources for Universal Health Coverage by Dr. Ngozi Okon...Ngozi Okonjo-Iweala
Keynote Address Delivered by Dr. Ngozi Okonjo-Iweala, Chair of the Board of Gavi, the Vaccine Alliance at The First Universal Health Coverage Financing Forum Organised by the World Bank Group, and USAID Attended by Health and Finance Ministers and Health Experts.
Australia spends much more on health care expenditure than on health promotion and prevention. Only 1.7% of total health expenditure in 2011-12 went to public health activities focused on prevention. However, chronic diseases place a large burden on the health system and are often preventable. More funding for prevention strategies could help control rising health costs by reducing rates of chronic illness. While some progress has been made, Australia still spends less on prevention than many other developed countries. Increased investment in primary care and prevention is needed to adequately address challenges from chronic diseases and an aging population.
The more honest one is, the easier it is to continue being honest, just as more lies one has told, the more necessary it is to lie again. By their openness, people dedicated to the truth live in the open, and through the exercise of their courage to live in the open, they become free from fear. Human beings are poor examiners, subject to superstition, bias, prejudice, and a PROFOUND tendency to see what they want to see rather than what really there. The ultimate goal of life remains the spiritual growth of the individual, the solitary journey to peaks that can be climbed only alone.
- M. Scott Peck, “The Road Less Traveled”
Physician Expectations and Primary Care Shortages: Evidence from the Affordab...Gerrit Lensink
This paper is the first installment in my undergraduate thesis on physician expectations and their effect on primary care shortages in the United States. Over following semesters I will be strengthening my research with econometric models and further analysis. Updates will follow as completed.
This document summarizes findings from tracking development assistance for health (DAH) globally. It discusses methods for estimating DAH from 1990-2010, key findings on trends in DAH and recipient government responses. It also outlines uncertainties in future global health financing due to economic conditions and priorities among donors. DAH has increased dramatically for HIV/AIDS, malaria and tuberculosis but less for maternal and child health and non-communicable diseases. On average, recipient governments decrease health spending by 43 cents to $1.14 for every dollar of DAH received. The outcome on future global health financing depends on donor priorities during fiscal contraction periods.
Ghana faces a dual burden of both communicable and non-communicable diseases. While malaria and diarrhea remain problems, non-communicable diseases like hypertension, stroke and diabetes are increasingly common causes of death. Ghana's health system struggles to address this growing disease burden due to underfunding and understaffing of the National Health Insurance system. Policy changes are needed to improve sanitation, health education, and ensure universal access to healthcare through increased funding from taxes and the formal sector.
Health Outcomes: What Does the Evidence Tell us about the Impact of Health Sy...HFG Project
Presented at USAID's Global Health Mini-University, March 2016.
Laurel Hatt (HFG), Ben Johns (HFG), Joe Naimoli (USAID/GH/OHS)
USAID’s Office of Health Systems and the HFG Project recently launched the Impact of Health Systems Strengthening on Health report, which for the first time presents a significant body of peer-reviewed evidence linking health systems strengthening interventions to measurable impacts on health outcomes. The report identifies 13 types of health systems strengthening interventions with quantifiable effects. It shares evidence on how to strengthen health system performance to achieve sustainable health improvements at scale, particularly toward EPCMD, an AFG, and protecting communities against infectious diseases. Interventions were found to be associated with reductions in mortality and morbidity for a range of conditions, including diarrhea, malnutrition, low birth weight, and diabetes. HSS interventions are also associated with improvements in service utilization, financial protection, and quality service provision.
The document summarizes findings from a report that tracked global development assistance for health from 1990 to 2007. It found that development assistance for health nearly quadrupled over this period, fueled primarily by increases in funding for HIV/AIDS. New actors like the Global Fund and GAVI accounted for an increasing share of assistance. While disease burden and income levels influenced funding allocations, political and economic factors also appeared to play a role in determining which countries received assistance. The report aims to continue annually tracking development assistance to better inform global health policies and priorities.
Sustaining the HIV/AIDS Response in Dominica: Investment CaseHFG Project
The document summarizes an analysis of the HIV epidemic and response in Dominica using the Goals model. Three scenarios were modeled: 1) maintenance of current programs, 2) scale-up to levels outlined in the national strategic plan, and 3) achieving 90-90-90 targets by 2020. The analysis estimates the impact on new infections, deaths, and people receiving ART under each scenario. It also projects the financial resources needed and potential funding gaps for Dominica's HIV response through 2020. The results are intended to help prioritize resource allocation and identify opportunities to improve the efficiency and impact of Dominica's national HIV/AIDS program.
HFG Dominican Republic Final Country ReportHFG Project
The Health Finance and Governance (HFG) Project worked in the Dominican Republic from 2016-2018 to help strengthen the country's HIV response and move towards sustainability. Through analyses and stakeholder workshops, HFG helped build consensus around including antiretroviral drugs in national health insurance and expanding treatment coverage nationwide. HFG also provided technical assistance to improve HIV service delivery in areas like supply chain management and clinic operations. As a result of HFG's work, financial sustainability is now a priority and plans are in place to transition the HIV response to domestic financing sources by reforming health insurance.
Trends in health financing and the private health sector in the middle east a...HFG Project
In the past several decades, countries in the Middle East and North Africa have made significant improvements in developing their health systems and improving the health status of their populations. However, the region continues to face substantial and diverse political, macroeconomic,social, and health challenges. In 2010–2011, the mass uprisings over high unemployment, poverty, and political repression known as the Arab Spring began in several countries. These events led to a wave of social and political upheaval that had enduring repercussions throughout the region. Iraq, Libya, Syria, and Yemen remain embroiled in prolonged violent conflicts. Other countries are more stable but undergoing significant changes and reforms.
To understand current health financing policies and mechanisms, as well as the current role of the private sector in the health systems of the Middle East, the USAID Middle East Regional Bureau commissioned the Sustaining Health Outcomes through the Private Sector (SHOPS) Plus and Health Finance and Governance (HFG) projects to conduct a review of health financing and the private health sector in the 11 low-and middle-income countries in the region, focusing on the years 2008 to 2017.1 The countries included in this analysis are Algeria, Egypt, Iraq, Jordan, Lebanon, Libya, Morocco, Syria, Tunisia, the West Bank and Gaza, and Yemen. This review aims to highlight regional trends and identify gaps in information.
Alternative approaches for sustaining the HIV and AIDS response in Dominican ...HFG Project
The purpose of this report is to capture and consolidate the suggestions of the Sustainability Group for consideration by the Government of Dominican Republic (GODR) and other relevant stakeholders. GODR will be able to draw from this report when developing its HIV sustainability strategy, revising the National Strategic Plan for HIV (PEN), and developing other planning and policy documents.
HFG began working in Namibia in 2013, closely partnering with the Namibian Ministry of Health and Social Services and going on to collaborate with key government agencies, such as the Namibian Social Security Commission and the Universal Health
Coverage Advisory Committee of Namibia. The overarching aim of our technical assistance has been to support Namibia’s progress toward UHC to ensure all can access necessary, quality health care without financial struggle. We emphasized a government-led and -owned approach as we supported the Namibian government in addressing some of the key challenges it faced at the start of the project.
HFG’s support has helped strengthen the government’s capacity to mobilize and manage resources; improve efficiency, quality, and equity of health services; expand access to health care; sustain key health interventions, especially the HIV/AIDS prevention, care, and treatment program; and, ultimately, identify sustainable financing for UHC. We provided technical support to the Namibian government’s Health Accounts team, equipping them with tools and know-how to lead and implement four Health Accounts exercises and analyze and present data for better policy analysis and evidence-based decision making. Our support has helped institutionalize Health Accounts in Namibia and provided the country’s policymakers with evidence to examine health financing options for UHC, advocate for greater resources, and explore financial risk protection options.
Strengthening the larger health system and generating fiscal space through improved efficiency of health services was another important goal for HFG.
Findings of the health facility costing and district hospital efficiency study we undertook will enable the government to identify where it can save resources, how it can improve equity in service distribution, and what Namibia’s total financing requirement is for UHC.
This report highlights some of the major contributions HFG and its key partners have made toward more efficient use of limited health resources, improved sustainability of
health programs, and progress toward UHC in Namibia.
Monitoring progress towards universal health coverage at country and global l...The Rockefeller Foundation
A movement towards universal health coverage (UHC) – ensuring that everyone who needs health services is able to get them, without undue financial hardship – has been growing across the globe (1). This has led to a sharp increase in the demand for expertise, evidence and measures of progress and a push to make UHC one of the goals of the post-2015 development agenda (2). This paper proposes a framework for tracking country and global progress towards UHC; its aim is to inform and guide these discussions and assessment of both aggregate and equitable coverage of essential health services as well as financial protection. Monitoring progress towards these two components of UHC will be complementary and critical to achieving desirable health outcome goals, such as ending preventable deaths and promoting healthy life expectancy and also reducing poverty and protecting household incomes.
This paper was written jointly by the World Health Organization (WHO) and The World Bank Group on the basis of consultations and discussions with country representatives, technical experts and global health and development partners (3). A draft of this paper was posted online and circulated widely for consultation between December 2013 and February 2014. Nearly 70 submissions were received from countries, development partners, civil society, academics and other interested stakeholders. The feedback was synthesized and reviewed at a meeting of country and global experts in Bellagio, Italy, in March 2014 (4). The paper was modified to reflect the views emerging from these consultations.
1) The World Health Organization (WHO) report "Health for the world's adolescents" addresses improving health outcomes for the world's one billion adolescents. It highlights both successes, such as declining adolescent pregnancy and maternal mortality rates in some regions, as well as ongoing challenges like HIV mortality among adolescents rising in Africa.
2) Adolescence is a crucial life stage for establishing health behaviors and patterns that affect future adult health. Many major causes of illness and death among adolescents, like road injuries, violence, and mental health issues, have preventable underlying factors.
3) Achieving overall health and development requires a holistic, multisector approach that addresses individual, social, and environmental determinants of adolescent health
Preparing for future shocks: Building resilient health systemsHFG Project
Presentation at USAID's Global Health Mini-University on Friday, March 4, 2016.
Preparing for Future Shocks: Building Resilient Health Systems
Kate Greene (HFG), Bob Emrey (USAID/GH/OHS), Jodi Charles (USAID/GH/OHS), Temitayo Ifafore, (USAID/GH/OHS)
After the recent Ebola outbreak, global health experts have turned to resilience frameworks used by other fields such as agriculture and engineering to understand how to build health systems that can withstand shocks, including infectious disease outbreaks, natural disasters, and political conflict. Speakers will first briefly outline each of the five key elements of the Resilience Framework, adapted from the Rockefeller Foundation and presented in a Lancet article in 2015, that can be applied to health systems. Participants will then work in small groups to discuss which health systems interventions should be pursued in response to a one-page description of an unnamed country. Speakers will then reveal what real-world interventions they designed for the country example and answer questions.
The document analyzes alternatives for Haiti's government to provide HIV medication to its citizens. It discusses that Haiti currently has 120,000 people living with HIV but the government lacks resources to provide medication. The status quo alternative relies on NGOs like PSI to fund programs, but long-term stability is uncertain if NGOs withdraw support. A second alternative is passing an anti-discrimination law to reduce barriers patients face in accessing care. The document evaluates alternatives based on percentage of patients treated, cost-effectiveness, and feasibility of implementation in Haiti's unstable political environment.
The Health Finance and Governance Briefing KitHFG Project
Resource Type: Brief
Authors: Megan Meline, Lisa Tarantino, Jeremy Kanthor, and Sharon Nakhimovsky
Published: September 2015
Resource Description: Getting access to affordable, quality health care is a universal story that touches virtually every family in the world. At the same time, providing quality health services and access to trained health professionals is a challenge for governments. The World Health Organization (WHO) estimates that 150 million people worldwide face “catastrophic expenditure” because of high costs of health care. In other words, they may have to forgo paying for basic needs, such as food, housing, or education to pay for medical treatment instead. These costs include transportation, doctors’ fees, medicine, hospitalization bills, and days lost from work.
Behind these sobering statistics lies a wealth of news and feature stories waiting for the media to investigate and share with national leaders and policymakers as well as civil society groups who can advocate for changes to health budgets and policies. At the heart of these stories are important questions about the financing of health care and the quality of governance that ensures responsive and effective management of those resources and services.
But writing health finance and governance stories can be challenging. Health finance is riddled with complex language, technical economic terms, and numbers – not necessarily a journalist’s comfort zone. The right sources for these stories can be difficult to identify and unwilling to talk. Data may be difficult to locate or to understand. And while corruption makes for splashy headlines, the broader systemic challenges of health governance are not widely understood — and yet they are important.
The Health Finance and Governance Briefing Kit is designed to help journalists and their editors uncover and tell these important health stories that affect people all around the world.
Mobilizing Domestic Resources for Universal Health Coverage by Dr. Ngozi Okon...Ngozi Okonjo-Iweala
Keynote Address Delivered by Dr. Ngozi Okonjo-Iweala, Chair of the Board of Gavi, the Vaccine Alliance at The First Universal Health Coverage Financing Forum Organised by the World Bank Group, and USAID Attended by Health and Finance Ministers and Health Experts.
Australia spends much more on health care expenditure than on health promotion and prevention. Only 1.7% of total health expenditure in 2011-12 went to public health activities focused on prevention. However, chronic diseases place a large burden on the health system and are often preventable. More funding for prevention strategies could help control rising health costs by reducing rates of chronic illness. While some progress has been made, Australia still spends less on prevention than many other developed countries. Increased investment in primary care and prevention is needed to adequately address challenges from chronic diseases and an aging population.
The more honest one is, the easier it is to continue being honest, just as more lies one has told, the more necessary it is to lie again. By their openness, people dedicated to the truth live in the open, and through the exercise of their courage to live in the open, they become free from fear. Human beings are poor examiners, subject to superstition, bias, prejudice, and a PROFOUND tendency to see what they want to see rather than what really there. The ultimate goal of life remains the spiritual growth of the individual, the solitary journey to peaks that can be climbed only alone.
- M. Scott Peck, “The Road Less Traveled”
Physician Expectations and Primary Care Shortages: Evidence from the Affordab...Gerrit Lensink
This paper is the first installment in my undergraduate thesis on physician expectations and their effect on primary care shortages in the United States. Over following semesters I will be strengthening my research with econometric models and further analysis. Updates will follow as completed.
This document summarizes findings from tracking development assistance for health (DAH) globally. It discusses methods for estimating DAH from 1990-2010, key findings on trends in DAH and recipient government responses. It also outlines uncertainties in future global health financing due to economic conditions and priorities among donors. DAH has increased dramatically for HIV/AIDS, malaria and tuberculosis but less for maternal and child health and non-communicable diseases. On average, recipient governments decrease health spending by 43 cents to $1.14 for every dollar of DAH received. The outcome on future global health financing depends on donor priorities during fiscal contraction periods.
Ghana faces a dual burden of both communicable and non-communicable diseases. While malaria and diarrhea remain problems, non-communicable diseases like hypertension, stroke and diabetes are increasingly common causes of death. Ghana's health system struggles to address this growing disease burden due to underfunding and understaffing of the National Health Insurance system. Policy changes are needed to improve sanitation, health education, and ensure universal access to healthcare through increased funding from taxes and the formal sector.
Health Outcomes: What Does the Evidence Tell us about the Impact of Health Sy...HFG Project
Presented at USAID's Global Health Mini-University, March 2016.
Laurel Hatt (HFG), Ben Johns (HFG), Joe Naimoli (USAID/GH/OHS)
USAID’s Office of Health Systems and the HFG Project recently launched the Impact of Health Systems Strengthening on Health report, which for the first time presents a significant body of peer-reviewed evidence linking health systems strengthening interventions to measurable impacts on health outcomes. The report identifies 13 types of health systems strengthening interventions with quantifiable effects. It shares evidence on how to strengthen health system performance to achieve sustainable health improvements at scale, particularly toward EPCMD, an AFG, and protecting communities against infectious diseases. Interventions were found to be associated with reductions in mortality and morbidity for a range of conditions, including diarrhea, malnutrition, low birth weight, and diabetes. HSS interventions are also associated with improvements in service utilization, financial protection, and quality service provision.
The document summarizes findings from a report that tracked global development assistance for health from 1990 to 2007. It found that development assistance for health nearly quadrupled over this period, fueled primarily by increases in funding for HIV/AIDS. New actors like the Global Fund and GAVI accounted for an increasing share of assistance. While disease burden and income levels influenced funding allocations, political and economic factors also appeared to play a role in determining which countries received assistance. The report aims to continue annually tracking development assistance to better inform global health policies and priorities.
Sustaining the HIV/AIDS Response in Dominica: Investment CaseHFG Project
The document summarizes an analysis of the HIV epidemic and response in Dominica using the Goals model. Three scenarios were modeled: 1) maintenance of current programs, 2) scale-up to levels outlined in the national strategic plan, and 3) achieving 90-90-90 targets by 2020. The analysis estimates the impact on new infections, deaths, and people receiving ART under each scenario. It also projects the financial resources needed and potential funding gaps for Dominica's HIV response through 2020. The results are intended to help prioritize resource allocation and identify opportunities to improve the efficiency and impact of Dominica's national HIV/AIDS program.
HFG Dominican Republic Final Country ReportHFG Project
The Health Finance and Governance (HFG) Project worked in the Dominican Republic from 2016-2018 to help strengthen the country's HIV response and move towards sustainability. Through analyses and stakeholder workshops, HFG helped build consensus around including antiretroviral drugs in national health insurance and expanding treatment coverage nationwide. HFG also provided technical assistance to improve HIV service delivery in areas like supply chain management and clinic operations. As a result of HFG's work, financial sustainability is now a priority and plans are in place to transition the HIV response to domestic financing sources by reforming health insurance.
Sustaining the HIV and AIDS Response in St. Kitts and Nevis: Investment Case ...HFG Project
The HIV/AIDS program in St. Kitts and Nevis is at a turning point, facing both opportunities to expand and target its efforts and threats of decreasing funding. As its National HIV/AIDS Strategic Plan expires in 2014, the country must consider whether and how to revise strategic priorities related to controlling and mitigating the effects of the epidemic. Critical decisions must be made about programming and budgeting for the HIV response in the coming years.
This brief provides analytic inputs to help St. Kitts and Nevis develop an “investment case” for its HIV/AIDS program. UNAIDS and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) have encouraged the small-island countries of the eastern Caribbean to develop HIV investment cases – reports that aim to help program leaders target investments on the interventions and populations where they will have maximum impact, given limited resources (UNAIDS 2012).
Hfg barbados costing community hiv final reportHFG Project
Barbados is currently experiencing tight fiscal constraints due to the slowdown of economic growth coupled with the fact that as a high-income country, it now no longer qualifies for concessional loan arrangements and grants from development partners. The President’s Emergency Plan for AIDS Relief (PEPFAR) has indicated a plan to reduce, and eventually cease, funding for HIV programs in Barbados, within the next two years. Given the current funding environment, the Ministry of Health and Wellness is looking for ways to continue financing the program through improved efficiency and by making evidence-based investments into cost-effective interventions. They are also seeking ways to identify new approaches to financing, which will allow continued health coverage and maintain the gains seen in the sector.
Civil society organizations (CSOs) began offering community-level HIV interventions in 2017, including testing, treatment, and social support to key populations. Some of these populations are highly stigmatized, so community outreach is perceived as necessary. Community-based services are expected to result in improved outcomes for these populations (e.g., reduced loss to follow-up and higher retention in care, improved adherence to treatment). This outreach could be particularly valuable in supporting the government’s adoption of the WHO-recommended Treat All strategy by helping to link persons living with HIV (PLHIV) to treatment and promote adherence.
This study assesses the cost of HIV-related services provision at the CSO level. It aims to benefit both the CSOs themselves and the government of Barbados. The government will be able to consider the results in deciding whether or how to allocate funds to CSOs to enable the CSOs to provide some key services when PEPFAR funding ceases. This study is one of several HFG activities implemented in four countries in the Caribbean to prepare the countries for donor transition.
Sustaining the HIV/AIDS Response in Antigua and Barbuda: Investment Case BriefHFG Project
Antigua and Barbuda has made great strides in organizing its response to HIV and AIDS in recent years, and has managed to control the growth of the epidemic. The National AIDS Program (NAP) is now at a critical juncture as the country plans to adapt to the changing donor funding landscape, new clinical guidelines, strategic objectives, and changes in policy including greater program integration into primary care, which are designed to increase access and reduce the cost of service delivery.
This document provides analytic inputs that support a case for investment in the Antigua and Barbuda HIV and AIDS response. This report provides a quantitative analysis of trends in the HIV epidemic and the impact of various prevention and treatment efforts to date, along with a projection of possible future programming scenarios, their costs, and their implications for the epidemic. The report describes estimated funding available and gaps in funding that The Goals and Resource Needs models – part of the Spectrum/OneHealth modeling system that estimates the impact and costs of future prevention and treatment interventions – were used for this analysis.
Lessons Learned for Strengthening Early Infant Diagnosis of HIV ProgramsHFG Project
This document summarizes lessons learned for strengthening early infant diagnosis (EID) of HIV programs in sub-Saharan Africa based on a literature review and the Health Finance and Governance project's work in Kenya. The main challenges identified are patient loss to follow up throughout the EID testing process, long turnaround times between sample collection and result receipt, and failure to initiate antiretroviral therapy for HIV-positive infants. Countries have implemented interventions like community outreach, point-of-care testing, and data dashboards to address these challenges. In Kenya, EID testing costs were measured and turnaround times analyzed, finding an average of 43 days between sample collection and result receipt.
Barbados 2012-13 Health Accounts ReportHFG Project
This report presents the findings and policy implications of Barbados’ first Health Accounts estimation, conducted for the year April 2012 to March 2013. It captures spending from all sources: the government, non-governmental organizations, external donors, private employers, private insurance companies and households. The analysis presented breaks down spending to the standard classifications, as defined by the System of Health Accounts 2011 framework, namely sources of financing, financing schemes, type of provider, type of activity and disease/health condition.
The USAID Health Finance and Governance project helps developing countries expand access to healthcare through improving health financing, management of resources, and purchasing decisions. Led by Abt Associates, the project works with partner countries in over 40 countries to mobilize domestic funding for health, enhance governance and accountability, improve management systems, and advance universal health coverage. The project is funded by USAID from 2012-2018 and involves several organizations.
South Africa HIV and TB Expenditure Review 2014/15 - 2016/17. Executive SummaryHFG Project
The South African Government (SAG) and its development partners have mounted a formidable response to the world’s largest HIV epidemic and a persistent burden of tuberculosis (TB), the country’s leading killer. Nearly 4 million South Africans initiated antiretroviral therapy (ART) by the end of financial year 2016/17, helping to curtail new infections and reduce the number of annual HIV-related deaths. Mortality from TB has also declined thanks, in part, to improved treatment success.
Despite progress, challenges remain. Roughly 3 million people living with HIV (PLHIV) lack treatment, and each year more than a quarter million are newly infected. Moreover, nearly a half million South Africans contract TB every year, with an increasing share affected by drug-resistant strains.
To effectively plan and steward the health system, the SAG routinely monitors programmatic and financial performance of the response to HIV and TB, including by tracking expenditure. Analysis of spending, including trends in sources, levels, geographic and programmatic distribution and cost drivers can help policymakers to assess whether resources are reaching priority populations, interventions, and hotspot geographies; to identify potential opportunities to improve allocative and technical efficiency; and to stimulate more productive dialogue at multiple levels of the system.
This review of HIV and TB expenditure in South Africa is an input to policy, planning and management processes within and amongst spheres of government and between government and development partners. The data have been especially useful to national and provincial programme managers as they perform their oversight functions, leading to improved spending of available resources. With 52 annexes, it also serves as an authoritative reference document detailing levels and trends in HIV and TB spending by the three main funders of the disease responses: the SAG, the United States Government (USG), primarily via the President’s Emergency Plan for AIDS Relief (PEPFAR), and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund). The findings have informed South Africa’s report to the UNAIDS Global AIDS Monitor and the country’s forthcoming funding request to the Global Fund.
The USAID Health Finance and Governance project, led by Abt Associates, works with developing countries to expand access to healthcare. It helps countries increase domestic health funding, better manage those resources, and make wise purchasing decisions. The project has worked in Cote d'Ivoire since 2013 to address challenges in human resources, health financing, and governance that were preventing effective delivery of HIV and other health services. Key accomplishments include a six-fold increase in the number of health workers trained to provide HIV treatment through task-sharing policies and curriculum changes.
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...AIDSTAROne
This technical report discusses the many services needed throughout the prevention of mother-to-child transmission (PMTCT) and infant care services continuum and identifies potential barriers to service coverage, access, and utilization. AIDSTAR-One provides examples of evidence-based and emerging practices to mitigate these barriers.
www.aidstar-one.com/focus_areas/pmtct/resources/report/increasing_access_to_pmtct_services
2021 HIV HEALTH SECTOR ANNUAL REPORT.pdfMercy Morka
The document provides an overview of Nigeria's national HIV/AIDS monitoring and evaluation systems, which utilize both paper-based and electronic tools like monthly summary forms, electronic medical records, and the National Data Repository to collect and report HIV program data. It notes challenges with timely and comprehensive reporting of data from states. NASCP is working to improve reporting through expanding the National Data Repository and integrating HIV data more fully into the national DHIS2 platform.
Less than a decade ago , the idea that most nations in the world would commit to working toward achieving Universal Health Coverage (UHC) was seen as unlikely, and certainly not a priority for the global health community. Today, we face an entirely different landscape. Since the 2010 World Health Report Health Systems Financing: The Path to Universal Coverage, more than 70 countries have approached WHO to request technical assistance in moving forward on UHC. A movement has built among global and national actors, leading to the passage of the UN Resolution endorsed by more than 90 countries in December 2012 to make UHC a key global health objective. Commitment is increasing for UHC to be the umbrella health goal in the post-2015 framework.
Strategic Review: Towards a Grand Convergence for Child Survival and HealthCORE Group
This document summarizes a strategic review of options for improving integrated management of newborn and childhood illness (IMNCI) going forward. The review draws on data from over 90 countries and hundreds of experts. Key findings are: 1) While IMNCI has helped transform child health services, interest and funding have declined and scale-up was rarely achieved; 2) To achieve ambitious new child mortality targets, health systems must be strengthened and universal health coverage ensured; 3) The review proposes renewing focus and action on IMNCI through a "Grand Convergence" to end preventable child deaths, supported by domestic and international financing. The goal is high quality care across home, community and health facilities as part of reproductive, maternal
An Assessment of PEPFAR partnership frameworks and Partnership framework impl...HFG Project
The document summarizes a study that assesses Partnership Frameworks (PFs) and Partnership Framework Implementation Plans (PFIPs) between PEPFAR and partner governments. It finds that the PFs/PFIPs advanced partnership dialogue and alignment between USG mandates and national priorities. They helped scale up high impact HIV interventions and identified focus areas around supply chain, domestic financing, and human resources. The process of developing the agreements engaged a wide range of partners and epitomized country ownership. However, sustainability challenges remain around continued domestic resource mobilization and health systems strengthening.
The document provides a health profile of Benue State, Nigeria. It summarizes key health indices like tuberculosis prevalence (13,000+ affected), HIV prevalence (15.4%), and stakeholders involved in health. It describes USAID/HFG project interventions in the state like budget advocacy, capacity building, and establishing a Resource Mobilization Technical Working Group. The project achieved a 62% increased budget allocation and release of previously withheld funds. Challenges included limited time and insecurity, while recommendations focused on ownership, capacity building and longer timelines.
Universal Health Coverage: Frequently Asked QuestionsHFG Project
This brief answers several “frequently asked questions” (FAQ) on universal health coverage (UHC):
What is Universal Health Coverage (UHC)?
How does UHC align with USAID’s priorities?
How does UHC relate to broader goals for development, including the Sustainable Development Goals?
How is UHC measured?
What progress has been made towards UHC?
How does USAID support countries’ UHC efforts?
The FAQ accompanies Universal Health Coverage: An Annotated Bibliography, which presents resources that provide an overview of UHC and also delve into specific topics within UHC, such as measurement, health financing, and benefit plans. The bibliography also includes links to relevant websites that can provide additional resources.
Getting Health’s Slice of the Pie: Domestic Resource Mobilization for HealthHFG Project
Many low- and middle-income countries have experienced strong economic growth in recent years, resulting in increased capacity for social sector spending. Net energy importers have further benefited from falling fossil fuel prices. At the same time donors are preparing to scale back development assistance, including support for global health initiatives. Responding to a lack of practical guidance on how countries can mobilize more domestic resources for the health sector, the Health Finance and Governance (HFG) project organized a series of joint learning workshops to promote knowledge exchange, share new and existing resources, and support countries in a DRM-for-health action planning process.
Similar to Sustaining the HIV and AIDS Response in St. Vincent and the Grenadines: Investment Case Brief (20)
This document outlines a training manual for a hospital costing workshop. It provides an agenda for the 3-day workshop covering topics like the fundamentals of costing, the MASH costing tool, and calculating unit costs. The workshop aims to teach participants how to conduct costing exercises to understand their hospital's costs and improve management. Sessions include introductions, an overview of costing concepts, the costing process, and a demonstration of the MASH tool which is an Excel-based framework for tracking and analyzing hospital resources, services, and costs.
Trinidad and Tobago 2015 Health Accounts - Main ReportHFG Project
This document summarizes the key findings of the 2015 health accounts report for Trinidad and Tobago. It finds that total health expenditure was 4.5 billion TT dollars in 2015, equivalent to 4.1% of GDP. The government financed 41% of health spending, while households financed 35% through direct out-of-pocket payments. Noncommunicable diseases accounted for the largest share of recurrent health spending at 42%. Out-of-pocket payments remain high, comprising over a third of total health expenditure. The report recommends strengthening government commitment to health financing, increasing risk pooling to reduce out-of-pocket spending, improving access to services, and institutionalizing ongoing health accounts estimations.
Guyana 2016 Health Accounts - Dissemination BriefHFG Project
The 2016 Guyana Health Accounts study found that:
1) Total health expenditure in Guyana was $28.6 billion (Guyanese dollars), with the government contributing 81% of funding.
2) The majority (71%) of health funds were spent on public health facilities like hospitals and clinics.
3) Most funds (64%) were spent on curative care services, while non-communicable diseases received the largest share (34%) of funds.
4) Government funding represents the largest source of financing for HIV/AIDS programs and services in Guyana, providing 62% of funds.
Guyana 2016 Health Accounts - Statistical ReportHFG Project
The document provides an overview of Guyana's 2016 Health Accounts methodology. It summarizes key aspects of the System of Health Accounts 2011 framework used, including boundaries, classifications, and definitions. Data was collected from government, households, NGOs, employers, insurers, and donors to track financial flows for health for 2016. The results help understand Guyana's health financing and answer questions on spending patterns.
Guyana 2016 Health Accounts - Main ReportHFG Project
The document summarizes the key findings of Guyana's first Health Accounts exercise for fiscal year 2016. It found that total health expenditure was G$ 28.6 billion, with the government contributing 81% of funding. Household out-of-pocket spending accounted for 9% of total spending. Non-communicable diseases received the largest share of spending at 34%. The analysis aims to inform strategic health financing decisions and assess domestic resource mobilization as external donor funding declines. Recommendations include increasing prevention spending and strengthening financial commitment to HIV programs.
The Next Frontier to Support Health Resource TrackingHFG Project
The document discusses challenges and opportunities for institutionalizing health resource tracking (HRT) in low- and middle-income countries. It identifies three key elements needed for institutionalization: strong demand for HRT data; sustainable local capacity to produce HRT data; and use of HRT results in policy and decision making. It outlines remaining challenges in each area and suggestions for future investments to address challenges, such as building understanding of HRT's value, maintaining local expertise, improving health information systems, and strengthening communication and use of HRT findings.
Rivers State has a population of over 7 million people from various ethnic groups. The main occupations are fishing, farming, and trading. The state has high rates of tuberculosis, neonatal and under-5 mortality, and HIV prevalence. Key stakeholders in health include the Ministry of Health, Ministry of Finance, and various agencies. The USAID Health Finance and Governance project worked to increase domestic health financing through advocacy, establishing a health insurance scheme, and capacity building. These efforts led to increased health budgets, establishment of healthcare financing units, and improved sustainability of health financing in Rivers State.
ASSESSMENT OF RMNCH FUNCTIONALITY IN HEALTH FACILITIES IN BAUCHI STATE, NIGERIAHFG Project
This document summarizes an assessment of reproductive, maternal, newborn and child health (RMNCH) services in health facilities in Bauchi State, Nigeria. It found that infrastructure like electricity, water and toilets were lacking in many facilities. There were also shortages of skilled healthcare workers, especially midwives, and staff training. While many facilities offered antenatal care and immunizations, availability of emergency obstetric and newborn care and services like postnatal care and post-abortion care were more limited. Supplies of essential medicines, equipment and guidelines were also often inadequate. Community outreach was provided by some facilities but could be expanded.
BAUCHI STATE, NIGERIA PUBLIC EXPENDITURE REVIEW 2012-2016 HFG Project
This document summarizes a public expenditure review of health spending in Bauchi State, Nigeria from 2012 to 2016. It finds that while Bauchi State's health budget increased over this period, actual health spending lagged behind budgeted amounts. Specifically, health spending accounted for a small and declining share of the state's total budget and expenditure. The review recommends that Bauchi State increase and better target public health funding to improve health outcomes and progress toward universal health coverage goals.
HEALTH INSURANCE: PRICING REPORT FOR MINIMUM HEALTH BENEFITS PACKAGE, RIVERS ...HFG Project
This document provides a pricing report for a Minimum Health Benefit Package (MHBP) being developed by Rivers State government in Nigeria. It analyzes the cost of 6 scenarios for the package, including individual and household premiums, based on medical claims data from hospitals in Rivers State from 2014-2017. The recommended annual premiums range from N14,026 to N111,734 for individuals and N79,946 to N636,882 for households, depending on the benefits included and the percentage of the state's population covered. The report provides context on data sources and actuarial assumptions used to determine the premiums.
The document is an actuarial report for Kano State's contributory healthcare benefit package in Nigeria. It analyzes 4 scenarios for the package - a basic minimum package alone or plus HIV/AIDS, tuberculosis, or family planning services. The report finds that the estimated annual premium per individual would be between N12,180-N12,600 depending on the scenario, while the estimated annual premium per household of 6 would be between N73,081-N75,595. It provides these estimates by analyzing the state's population data, healthcare facilities, utilization rates, and costs to determine the risk premiums, administrative costs, marketing costs, and contingency margins for each scenario. The report recommends rounding the premium estimates and includes
Supplementary Actuarial Analysis of Tuberculosis, LAGOS STATE, NIGERIA HEALTH...HFG Project
This document provides an actuarial analysis of including tuberculosis (TB) coverage in the Lagos State Health Scheme in Nigeria. It analyzes 3 different TB treatment regimens and estimates the additional premium required. Based on historical TB case data from 2013-2016, it projects the number of cases and costs for the next 3 years. The analysis finds the additional premium to be 488.79 Naira on average per person to cover TB screening tests and the 3 treatment regimens. It acknowledges limitations in the source data and outlines key assumptions made in the projections.
Supplementary Actuarial Analysis of HIV/AIDS in Lagos State, NigeriaHFG Project
This document provides a supplementary actuarial analysis of including HIV/AIDS coverage in the Lagos State Health Scheme benefit package in Nigeria. It estimates the total additional medical cost to cover HIV/AIDS services would be 209.40 Naira per person per year, broken down into costs for HIV testing and counseling (13.60), antiretroviral therapy (133.05), and preventing mother-to-child transmission (15.96). The analysis is based on HIV service data from 2012-2016 and projected population and drug cost data from the Lagos State Ministry of Health. It assumes a 90% continuation and conversion rate for antiretroviral therapy and a 6.5% annual medical cost trend.
Assessment Of RMNCH Functionality In Health Facilities in Osun State, NigeriaHFG Project
This document summarizes an assessment of reproductive, maternal, newborn and child health functionality in health facilities in Osun State, Nigeria. It was conducted by Abt Associates in collaboration with other organizations as part of the USAID Health Finance and Governance Project. The assessment aimed to determine service delivery readiness in primary health centers for the Basic Health Care Provision Fund pilot. Key findings included inadequate health facility infrastructure, shortages of health workers and equipment, and gaps in administrative and referral systems. The results provide baseline data on capacity for implementing health financing reforms in Osun State under the National Health Act.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
This particular slides consist of- what is hypotension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is the summary of hypotension:
Hypotension, or low blood pressure, is when the pressure of blood circulating in the body is lower than normal or expected. It's only a problem if it negatively impacts the body and causes symptoms. Normal blood pressure is usually between 90/60 mmHg and 120/80 mmHg, but pressures below 90/60 are generally considered hypotensive.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Tips for Pet Care in winters How to take care of pets.
Sustaining the HIV and AIDS Response in St. Vincent and the Grenadines: Investment Case Brief
1. November 2014
This publication was produced for review by the United States Agency for International Development.
It was prepared by Matt Hamilton, Matt Kukla & Elizabeth Conklin for the Health Finance and Governance (HFG)
and Strengthening Health Outcomes through the Private Sector Projects (SHOPS).
SUSTAINING THE HIV AND AIDS
RESPONSE IN ST. VINCENT AND THE
GRENADINES: INVESTMENT CASE BRIEF
2. The Health Finance and Governance Project
USAID’s Health Finance and Governance (HFG) project helps to improve health in developing countries by
expanding people’s access to health care. Led by Abt Associates, the project team works with partner countries to
increase their domestic resources for health, manage those precious resources more effectively, and make wise
purchasing decisions. As a result, this five-year, $209 million global project will increase the use of both primary
and priority health services, including HIV/AIDS, tuberculosis, malaria, and reproductive health services.
SHOPS Project
The Strengthening Health Outcomes through the Private Sector (SHOPS) Project is a five-year cooperative
agreement (2009-2014) with a mandate to increase the role of the private sector in the sustainable provision and
use of quality family planning, HIV/AIDS, and other health information, products, and services.
November 2014
Cooperative Agreement No: AID-OAA-A-12-00080
Cooperative Agreement No.: GPO-A-00-09-00007
Submitted to:
Rene Brathwaite
HIV/AIDS Specialist
USAID/ Barbados and the Eastern Caribbean
Scott Stewart, AOR
Office of Health Systems
Bureau for Global Health
United States Agency for International Development
Maggie Farrell
Population and Reproductive Health/Service Delivery Improvement
Bureau for Global Health
United States Agency for International Development
Recommended Citation: Kukla, Matthew, Matt Hamilton and Elizabeth Conklin. November 2014. Sustaining
the HIV and AIDS Response in St. Vincent and the Grenadines: Investment Case Brief. Bethesda, MD: Health Finance &
Governance Project, Abt Associates Inc.
Abt Associates Inc. | 4550 Montgomery Avenue, Suite 800 North | Bethesda, Maryland 20814
T: 301.347.5000 | F: 301.652.3916 | www.abtassociates.com
Broad Branch Associates | Development Alternatives Inc. (DAI) | Futures Institute
| Johns Hopkins Bloomberg School of Public Health (JHSPH) | Results for Development Institute (R4D)
| RTI International | Training Resources Group, Inc. (TRG)
3. SUSTAINING THE HIV
AND AIDS RESPONSE IN
ST. VINCENT AND THE
GRENADINES:
INVESTMENT CASE
BRIEF
DISCLAIMER
The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency
for International Development (USAID) or the United States Government.
5. i
CONTENTS
Contents.......................................................................................... i
Acronyms...................................................................................... iii
Acknowledgments......................................................................... 4
1. Background........................................................................ 5
1.1 St. Vincent and the Grenadines HIV and AIDS response .............5
1.2 Rationale ...................................................................................................5
2. Methods and Models ......................................................... 7
2.1 Methodology and data...........................................................................7
2.2 Modeling scenarios.................................................................................9
2.3 Limitations..............................................................................................10
3. Scenario Results .............................................................. 12
3.1 Impact of scenarios...............................................................................12
3.2 Scenario costs........................................................................................16
3.3 Resource availability analysis..............................................................19
3.4 Vulnerability to cuts in external funding .........................................22
3.5 Resource gap analysis ..........................................................................24
4. Conclusions.............................................................................. 26
Annex A: Inputs to the Goals & Resource Needs Models....... 29
Annex B: Epidemiological Parameters ..................................... 35
6. ii
List of Tables
Table 1: Coverage of Key Interventions-Three Model Scenarios
Table 2: HIV/AIDS Expenditures by Support Area and Funding Source (2012-2013)
Table 3: HIV/AIDS Expenditures by Funding Source (2012-2013)
Table 4: Resource Availability for HIV and AIDS Programming by Funding Source (2012-2018)
Table 5: Scenario Costs and Resource Availability from 2014-20, in millions of ECD.
Table 6: Comparative Cost-Effectiveness Metrics
List of Figures
Figure 1: Goals model fit to historical trend in HIV prevalence.
Figure 2: Model projection of the total number of new HIV infections annually, 2010-2025, for each
model scenario.
Figure 3: Model projection of the annual number of AIDS deaths among adults aged 15 and over, 2010-
2030, for each model scenario.
Figure 4: Model projection of the annual number of number of adults aged 15 and over eligible for
ART, 2010-2030, for each model scenario.
Figure 5: Model projection of the annual number of adults aged 15 and over receiving ART, 2010-2030,
for each model scenario
Figure 6: Break down of resources required by program element: Reduce Prevention scenario.
Figure 7: Break down of resources required by program element: Maintenance scenario.
Figure 8: Break down of resources required by program element: 90-90-90 in 2020 scenario.
Figure 9: Scenario costs and resource availability from 2014-20, in millions of ECD.
7. iii
ACRONYMS
ART Antiretroviral Therapy
ARV Antiretroviral
CSW Commercial Sex Workers
ECD Eastern Caribbean Dollars
HFG Health Finance and Governance
KfW German Development Bank
MARPs More-at-risk populations
MoHWE Ministry of Health, Wellness and the Environment
MSM Men who have sex with men
OECS Organization of Eastern Caribbean States
OVC Orphans and Vulnerable Children
PEPFAR President’s Emergency Plan for AIDS Relief
PLHIV People living with HIV/AIDS
PMTCT Prevention of Mother to Child Transmission
PSI Population Services International
SHOPS Strengthening Health Outcomes through the Private Sector
STI Sexually transmitted infections
SVG Saint Vincent and the Grenadines
UNAIDS Joint United Nations Program on HIV/AIDS
UNGASS United Nations General Assembly Special Session
USAID United States Agency for International Development
8. 4
ACKNOWLEDGMENTS
This brief is the result of contributions from many individuals, and would not have been possible without
their commitment of time and expertise. We are grateful for support from the Ministry of Health,
Wellness and the Environment, including the Permanent Secretary, Mr. Luis de Shong, Dr. Dell Hamilton
and Ms. Ferosa Roche. We are also grateful for inputs from Florence Otatunji, CHAA representative,
Patric Prescod, PSI Program Coordinator who gave of their time to identify additional data sources to
reflect work with MARPs and other prevention strategies in St. Vincent and the Grenadines. Finally, we
appreciate the inputs received from numerous participants during the validation meeting in July 2014.
9. 5
1. BACKGROUND
1.1 St. Vincent and the Grenadines HIV and AIDS response
The first reported cases of HIV/AIDS in St. Vincent and the Grenadines occurred in 1984 and peaked in
the early to mid-2000s. National surveillance reports estimate that there were about 649 persons living
with HIV in St. Vincent and the Grenadines at the end of 2011, which translates to 1.2% of the adult
population (15-49 years) or 0.7% of the total population. The epidemic is male-dominant, illustrated by
the fact that the cumulative case reporting from 1984-2013 indicates that 60.6% of new cases are
reported among males and 38.1% females (1.3% unknown). Targeted efforts have to focus on most-at-
risk populations (MARPS) due to the high prevalence among men who have sex with men (MSM)
(29.5%), prisoners (4%) and individuals involved in transactional sex(prevalence unknown).
In response to the growing epidemic, the country quickly scaled up its national HIV/AIDS program in
2004. While care and treatment remains a high priority, St. Vincent and the Grenadines has devoted
significant resources to preventative activities, including HIV counseling and rapid testing, education and
workplace programs, and other behavioral interventions. Important gains have been made in the
establishment of key prevention services like counseling and testing. Prevention of mother to child
transmission (PMTCT) and treatment and care interventions have reached coverage rates of 89% and
84%, respectively.
Despite a marked decline in HIV and AIDS cases, significant challenges for the country’s response
remain. Close to 20% of persons with advanced HIV infection discontinue treatment within 12 months
of initiation, suggesting the need to reinforce adherence and retention to care. The country also faces an
imminent decline in donor funding and domestic reprioritization of chronic and non-communicable
diseases; without renewed sources of external funding or greater domestic resources allocated to
HIV/AIDS, progress made since 2004 could regress.
In response to these challenges, key priorities outlined in the country’s strategic framework (2014-2025)
include: 1) institutionalizing HIV education through collaborative programs with different sectors, 2)
targeting high risk groups, 3) strengthening HIV testing and counseling, including routine testing for
pregnant women and, 4) ensuring access and retention to care and treatment for those with HIV and
AIDS and TB. St. Vincent and the Grenadines has also taken steps to integrate HIV and AIDS services
into the broader health system and included the HIV and AIDS program as part of the Ministry of
Health, Environment and Wellness’ overall health framework. These actions are the beginning of efforts
to improve access to care, reduce costs, and improve efficiencies.
1.2 Rationale
St. Vincent and the Grenadines is one of six Organization of Eastern Caribbean States (OECS) countries
applying for funding through the Global Fund’s New Funding Model, and it is contributing to a regional
Concept Note to be submitted in 2015. In January 2014, UNAIDS and the President’s Emergency Plan
for AIDS Relief (PEPFAR) held a meeting in Saint Lucia on the topic of “Strategic HIV Investment and
10. 6
Sustainable Financing” for nine small-island countries in the eastern Caribbean. During that meeting, the
two sponsoring agencies encouraged each participating country to prepare an HIV investment case – a
report that would identify opportunities to “improve country-level prioritization, technical efficiency and
decision making for the allocation of HIV program resources” (UNAIDS 2014).
A key component of UNAIDS’ investment framework is a quantitative analysis of trends in the HIV
epidemic, the impact of various prevention and treatment efforts to date, as well as a projection of
possible future programming scenarios and their implications for the epidemic and program costs. With
assistance from USAID-funded Health Finance and Governance and Strengthening Health Outcomes
through the Private Sector (SHOPS) Projects, this analysis was conducted using the Goals and Resource
Needs models. These tools are part of the Spectrum/OneHealth modeling system and estimate the
impact and costs of future prevention and treatment interventions.
Beyond the development of an investment case and Concept Note for new external funding, this
quantitative modelling will produce strategic information aimed to assist policymakers in St. Vincent and
the Grenadines in other ways. First, it will encourage the prioritization of limited resources for HIV and
AIDS to those interventions that are most likely to produce impact on the epidemic. It can also be used
to spur investments in programs that are both equitable and efficient, including leveraging private sector
partners to participate actively in the HIV and AIDS response. Second, these analyses will assist the
Ministry of Health and other key stakeholders to make a strong case for additional funding. It can be
used as a tool to explain why HIV and AIDS funding is crucial – both by explaining the harmful impact
that reduced funding will have on the epidemic and the gains that can be achieved if greater funding is
received.
11. 7
2. METHODS
AND MODELS
In this section, we describe the projection model developed to estimate trends in the HIV epidemic, the
projected impact of HIV and AIDS programs on the epidemic in terms of expected new infections, AIDS
deaths, and the number of people receiving anti-retroviral therapy (ART) under different scenarios, and
the potential costs of these future program options.
2.1 Methodology and data
2.1.1 Methodology
This analysis uses the Goals model1, a module implemented in the Spectrum modeling system that
estimates the impact of future prevention and treatment interventions. The Goals model partitions the
adult population aged 15-49 by age and sex and into six risk groups: not sexually active, low-risk
heterosexual (stable monogamous couples), medium-risk heterosexual (people engaging in casual sex
with multiple partners per year), high-risk heterosexual (female sex workers and their male clients), men
who have sex with men, and injecting drug users. The Goals model implements a dynamical
compartment model to project transmission forward in time and to model the costs and impact of
interventions that reduce transmission.
The Goals model calculates new HIV infections by sex and risk group as a function of behaviors and
epidemiological factors such as prevalence among partners and stage of infection. The risk of
transmission is determined by behaviors (number of partners, contacts per partners, condom use) and
biomedical factors (ART use, male circumcision, prevalence of other sexually transmitted infections).
Interventions can change any of these factors and, thus, affect the future course of the epidemic. The
Goals model uses an impact matrix that summarizes the international literature on the average impact of
each intervention type on these behaviors and biomedical factors to influence overall transmission in the
modeled population.2
The Goals model is linked to the AIM module in Spectrum, which calculates the effects on children
(aged 0-14) and individuals 50 and older. The AIM module also includes the effects of PMTCT programs
on pediatric infections.
1 Futures Institute. Goals manual: a model for estimating the effects of interventions and resource allocation on HIV
infections and deaths, August 2011. www.FuturesInstitute.org. [Accessed October 23, 2014].
2 Bollinger LA, How can we calculate the “E” in “CEA” AIDS 2008, 22(suppl 1): S51-S57.
12. 8
2.1.2 Data and assumptions
The model parameters and sources used are provided in Annex A. Data on the epidemiology of
HIV/AIDS in St. Vincent and the Grenadines, including historical surveillance of HIV prevalence and the
number of individuals receiving PMTCT and ART, were taken from the UNAIDS national estimates.
Validated international studies were used to set values of epidemiological parameters such as the per-act
probability of transmission and variation in risk of transmission by stage of infection, type of sex act,
prevalence of other sexually transmitted infections (STI), and use of condoms. The model was further
parameterized using a combination of country-specific published data sources whenever available. When
country-specific estimates were unavailable, estimates from published Caribbean regional sources or
expert opinion derived from interviews with clinicians and program staff familiar with the local epidemic
were used.
The model was first fit to the historical pattern of HIV prevalence in St. Vincent and the Grenadines in
order to reproduce the historical epidemic dynamics. Figure 1 displays the closeness of fit between
observed prevalence and the model-generated prevalence. The quality of this fit provides assurance that
the model will accurately predict future dynamics, subject to projected changes in program coverage. In
the figure, the blue triangles represent the trend in historical prevalence and the solid line reflects the
projection model.
Figure 1: Goals model fit to historical trend in HIV prevalence.
Specifically, the red line represents surveillance data on the HIV/AIDS epidemic from its inception in the
early 1980s (UNAIDS, 2001-2008). The number of HIV/AIDS cases in St. Vincent and the Grenadines
increases slowly until the mid-1990s, after which cases increase exponentially and then stabilize after
roughly 2011. The triangles are prevalence data from the Goals model and align well with existing
surveillance data, suggesting that the Goals model developed to predict each scenario is strong.
13. 9
2.2 Modeling scenarios
In consultation with the St. Vincent National AIDS Program, three model scenarios were developed.
Each reflects a possible set of changes in program coverage, corresponding to an increase or decrease in
resource expenditure. The scenarios are projected from a baseline year of 2013, the last full year for
which any data are available. They begin to diverge in 2015, the first year in which program changes will
begin. All three scenarios estimate changes in program coverage to be achieved by the year 2020. The
following scenarios are presented in depth in Table 4, which outline key indicators of the epidemic and
coverage estimates from behavioral and treatment interventions. These figures are used in the Goals
model to derive key outputs, such as the number of new HIV cases and AIDS deaths per annum.
2.2.1 Reduce Prevention
This scenario reflects the likely costs and activities of the NAP in the absence of any additional external
funding beyond what is currently projected in Table 3 above. Coverage of prevention programs drops
significantly in 2015, reflecting the decline in PEPFAR direct program funding, and remains constant
thereafter. Coverage of community mobilization efforts drops by 33%, condom provision by 20%, and
outreach among MSM, female sex workers, and their clients, drops by 67% relative to 2013 baseline.
The ART eligibility threshold increases from a CD4 count of 350 to 500 cells/μL in 2015, reflecting the
likely decision of the OECS nations to adopt new World Health Organization (WHO) eligibility
guidelines. This increases the pool of individuals eligible for ART; the percentage of eligible individuals
receiving ART (ART coverage) remains constant, but the number of people on ART increases as a result
of the expanded eligibility threshold.
2.2.2 Maintenance
Upcoming gaps in external funding are filled by increased domestic resources, a new Global Fund grant,
or other external funding not included in Table 3 above. This scenario reflects funding for prevention
programs such as community mobilization, condom provision, and outreach to MARPs remains constant
at current levels. However, the CD4 count threshold for ART eligibility remains constant at 350
cells/μL. ART coverage remains constant at present levels.
2.2.3 90-90-90 in 2020
This scenario reflects the UNAIDS proposed target levels of HIV program coverage by the year 2020
(90% of HIV positive individuals aware of their status; 90% of ART eligible individuals on ART; and 90%
of people on treatment have suppressed viral loads). Funding to prevention programs remains constant.
Voluntary counseling and testing coverage increases from 9% to 58% of the population in order to
capture 90% of all PLHIV aged 15-49. The CD4 threshold for ART eligibility increases from 350 to 500
cells/μL in 2015. ART coverage increases to 90% in 2020 and remains constant thereafter.
14. 10
Table 1: Coverage of Key Interventions-Three Model Scenarios
Intervention 2013 2020
Baseline Reduce
Prevention
(1)
Maintenance
(2)
90-90-90
(3)
Community mobilization 10% 6.7% 10% 10%
Percentage of the adult population
tested every year
9.0% 9.0% 9.0% 58%
Population covered by condom
promotion and distribution
62.5% 5.7% 44% 44%
Prevention outreach to sex workers 77.9% 25.7% 77.9% 77.9%
Prevention outreach to MSM 53.4% 17.6% 53.4% 53.4%
STI treatment 55% 55% 55% 55%
Blood safety 100% 100% 100% 100%
ART for eligible adults
Males 34.1% 34.1% 34.1% 90%*
Females 61.7% 61.7% 61.7% 90%*
ART for children* 80% 80% 80% 80%
PMTCT 100% 100% 100% 100%
2.3 Limitations
Goals is a globally-recognized tool for modeling the costs and impact of HIV programs, and is being used
in all OECS countries as well as other countries in the region, such as Guyana and the Dominican
Republic. However, the precision of any compartmental model can be limited in describing small
populations (less than ~100,000) with low HIV prevalence.
As noted in Annex A, this analysis used regional or global estimates for some behavioral parameters (i.e.
sex acts per partner, number of partners per year). Country-specific estimates were used whenever
available, but in some cases, it was necessary to use regional or global estimates. Similarly, some cost
estimates were drawn from regional estimates (i.e treatment service delivery costs drawn from an
Antigua and Barbuda study).
The estimated average impact of interventions, expressed in the Goals software’s impact matrix, is
drawn from a global review of the literature. This is commonly-accepted standard practice for modeling
15. 11
exercises of this type because sufficient intervention impact studies have not been performed at the
local or even the regional level.
Coverage estimates for St. Vincent and the Grenadines were unknown for some interventions, such as
mass media and counseling and testing. We used estimates from published documents where available,
supplemented with information from interviews with local stakeholders familiar with the programs.
16. 12
3. SCENARIO
RESULTS
3.1 Impact of scenarios
Four models were developed to assess and compare the impact of each scenario (Figures 2-6) on key
HIV/AIDS outcomes. Figure 2 presents the total number of new HIV infections annually, from 2010 to
2030. Each scenario would have a significantly different impact on the change in new HIV rates per year.
The reduce prevention scenario projects that the number of new HIV infections will increase sharply
from 2014 to 2015. The rate of new HIV infections will then rise by 3.3 cases per annum and eventually
reach 138 new infections per year by 2030 – the highest of any scenario. The maintenance scenario
predicts a constant and less marked increase of new HIV infections per year. By 2030, there would be
82 new infections per year in the maintenance scenario. Conversely, the 90-90-90 scenario shows a
steep decline in the number of new infections per year through 2020 and eventually levels off at roughly
54 new cases per year by 2030 – the lowest of any scenario.
Figure 2: Model projection of the total number of new HIV infections annually, 2010-2030, for each
model scenario.
17. 13
The number of AIDS-related deaths each year, by scenario, is presented in Figure 3. Once again, the 90-
90-90 scenario leads to the largest decline in AIDS-related deaths by 2030. This scenario suggests that in
2014 there are roughly 50 AIDS-related deaths in St. Vincent and the Grenadines, and there would be a
sharp decline of 4.7 AIDS-related deaths per year through 2021. From 2021 to 2030, the 90-90-90
scenario would see an increase in the number of AIDS-related deaths, resulting in 40 per year by 2030.
The maintenance scenario would lead to a gradual rise in AIDS-related deaths per year to 69 by 2030.
While the reduce prevention scenario would see a similar increase in AIDS-related deaths through
2015/16, on track with the maintenance scenario, the number of AIDS-related deaths would eventually
rise at a faster rate. This increased rate would result in 85 AIDS-related deaths per year by 2030.
Figure 3: Model projection of the annual number of AIDS-related deaths among adults aged 15 and
over, 2010-2030, for each model scenario.
Figure 4 projects the number of adults who are eligible and need ART, by scenario. In 2014, this figure is
slightly below 500 adults. In the maintenance scenario, the need for ART remains consistent such that by
2030 there are just over 500 adults per year needing ART. In the reduce prevention scenario, there is a
gradual rise in adults needing ART after 2016, which result in 675 adults needing ART by 2030. In the
90-90-90 scenario, the number of adults needing ART increases substantially through 2015 and tapers
off slightly through 2020. This marginal increase declines through 2030, where 870 adults will need
eventually ART coverage.
18. 14
Figure 4: Model projection of the annual number of number of adults aged 15 and over eligible for
ART, 2010-2030, for each model scenario.
While Figure 4 models the number of adults needing ART, Figure 5 predicts the number of adults
receiving ART through 2030. Given the significant increase in adults needing ART coverage in the 90-90-
90 scenario, this scenario indicates that roughly 66% of that demand is met through 2030. There is a
significant rise in those receiving ART from roughly 260 individuals in 2013 to 700 by 2021. Coverage
declines at a slow but constant rate thereafter, and just under 600 adults are covered by 2030. While
the reduce prevention scenario saw a gradual rise in adults needing ART through 2030, much less of this
demand is met. The marginal increase in the number of individuals who receive is small through 2030,
when only 290 adults are receiving treatment each year. In the maintenance scenario, the number of
adults needing ART treatment increases slighting through 2030, while the number of individuals who
receive that treatment declines through 2030. In the maintenance scenario, only 220 adults receive ART
treatment per year by 2030 compared to the roughly 500 who need it.
19. 15
Figure 5: Model projection of the annual number of adults aged 15 and over receiving ART, 2010-
2030, for each model scenario.
Table 6 gives the cost per infection averted and the cost per death averted over the five year period
2015-2020. Relative to the maintenance scenario, the 90-90-90 scenario costs an additional EC$115,516
per infection averted and EC$35,328 per death averted over this five-year period. Relative to the reduce
prevention scenario, the maintenance scenario costs an additional EC$88,168 per infection averted and
EC$683,496 per death averted. Calculation of these estimates is straightforward: the total five-year
difference in costs was divided by the total five-year difference in infections and deaths. These metrics
should not be interpreted as marginal costs, however, since all four will decrease over time. The very
high cost per death averted of the maintenance scenario relative to the reduced prevention scenario, for
example, is explained by realizing that reducing prevention activities has an immediate effect on
transmission, but only a delayed effect on mortality reduction. Over a longer period, this cost will
decrease dramatically.
Table 6: Comparative cost-effectiveness metrics
Cost per infection averted, 2015-2020
90-90-90 scenario relative to Maintenance scenario EC $115,516 (US $42,784)
Maintenance scenario relative to Reduced Prevention scenario EC $35,328 (US $13,085)
Cost per death averted, 2015-2020
90-90-90 scenario relative to Maintenence scenario EC $88,168 (US $32,655)
Maintenance scenario relative to Reduced Prevention scenario EC $683,496 (US $253,147)
Discounted at 3% per year. Exchange rate 1 USD = 2.7 ECD.
20. 16
3.2 Scenario costs
The resource needs model (RNM) is a tool to estimate the future cost of each scenario and is
developed in parallel with the GOALS model. The cost of St. Vincent and the Grenadines’ existing
HIV/AIDS program is roughly 4 million EC$ in 2014. Under the maintenance scenario, future costs
would be similar to current spending patterns given that St Vincent and the Grenadines’ HIV/AIDS
program would not change. Costs would rise gradually to 4.25 million EC$ by 2020. Under the reduce
prevention scenario, costs would slowly grow to around 3.5-4 million EC$ by 2020. The resources
required to fund this scenario would initially exceed that of the maintenance scenario. The resources
needed to achieve the reduce prevention scenario would eventually exceed those available. Costs for
the 90-90-90 scenario would increase rapidly after 2017/18 and the resource gap would be significantly
higher than any other policy option.
Figures 6-8 provide a more in-depth breakdown of each scenario by spending category, from 2013
through 2020. These categories include commercial sex workers, STI management, treatment, MSM,
voluntary counselling and testing, program support, condom promotion, and PMTCT. Figure 7 presents
resource needs for the domestic resource scenario. For 2013 and 2014, program support and condom
promotion together account for over 50% of total HIV/AIDS spending. After 2014, program support
continues to be a major cost driver, though the cost of condom promotion declines. Treatment costs
become a larger share of total costs in 2015, and by 2016 they become the largest source of costs for
the reduce prevention scenario. The relative cost of MSM and commercial sex workers declines over
time, while costs for VCT and STI management remain constant over the seven year period.
21. 17
Figure 6: Break down of resources required by program element: Reduce Prevention scenario.
Total costs in the maintenance scenario rise gradually from 2013 through 2020 (Figure 8). Spending on
commercial sex workers, STI management, MSM, condom promotion, and VCT remains constant over
the seven-year period. Similar to the reduce prevention scenario, condom promotion and program
support account for the largest share of total costs from 2013 to 2017, after which the share of
spending on treatment matches that spent on condom promotion. From 2017 to 2020, program
support, condom promotion, and treatment account for over 80% of total costs.
22. 18
Figure 7: Break down of resources required by program element: Maintenance scenario.
Figure 8 shows the break down in costs for the 90-90-90 scenario through 2020, where total costs
increase substantially after 2015. Over the seven-year period, spending on commercial sex workers,
MSMs, condom promotion, and STI management remain a stable and relatively small share of total costs.
The primary drivers of costs in the 90-90-90 scenario include program support, treatment, and
voluntary testing and counseling, which represent roughly 85% of total HIV/AIDS costs. By 2020, VCT
accounts for the largest share of HIV/AIDS spending among all programs.
23. 19
Figure 8: Break down of resources required by program element: 90-90-90 in 2020
scenario.
3.3 Resource availability analysis
Tables 2 and 3 provide data on HIV/AIDS expenditures for St. Vincent and the Grenadines (2012-2013),
broken down by funding source and area of support. The rise in expenditures from $3,959,853.89 ECD
in 2012 to $4,267,141.12 ECD in 2013 was due to a marginal increase in spending by the public sector
and most international donors. However, spending by SVG’s private sector, the Global Fund, and
PEPFAR remained constant over this period (UNGASS, 2014).
Total HIV/AIDS expenditures presented in Tables 2 and 3 include both direct and indirect spending.
Direct HIV/AIDS expenditures consist of funding allocated to care, treatment, and prevention. Indirect
HIV/AIDS expenditures include funding allocated to health systems strengthening, social protection,
orphans and vulnerable children, the enabling environment, and technical assistance. While total direct
spending on HIV/AIDS increased from 2012 to 2013 in absolute terms (by roughly $2,000,000 ECD) and
relative terms (by 2% of total expenditures), this was due to a substantial rise in prevention
expenditures for HIV/AIDS (Table 1). This increase made up for a significant decline in spending on care
and treatment from 2012 to 2013. Of direct HIV/AIDS expenditures, donor funding represented
between 55-70% of spending on care and treatment and nearly 100% of prevention spending. The
remainder of direct, HIV/AIDS expenditures was split almost evenly between public and private sources.
As a percent of total direct and indirect expenditures, prevention represented 28% in 2012 and 37% in
24. 20
2013, respectively; care and treatment accounted for 16% in 2012 and 9% in 2013, respectively
(UNGASS, 2014).
Among indirect HIV/AIDS expenditures in St. Vincent and the Grenadines, spending on orphans and
vulnerable children, social protection, and social services came entirely from the public sector. Public
funding for these support areas remained stagnant from 2012 to 2013. Spending on OVCs accounted for
13% of total HIV/AIDS expenditures, while funding for social protection and social services accounted
for roughly 3% of total HIV/AIDS expenditures.
Spending on health system strengthening for HIV/AIDS represented 39% of total direct and indirect
expenditures in 2012 and 35% in 2013. Of the $1,551,215.35 ECD spent on HSS in 2012, 59% came
from the public sector and the remaining 41% came from donors. In 2013 public sector spending on HSS
increased by roughly $80,000 ECD, while donor spending declined by $80,000 ECD (UNGASS, 2014).
Spending on the enabling environment came entirely from donors and accounted for only 1% of total
HIV/AIDS spending.
Table 2: HIV/AIDS Expenditures by Support Area and Funding Source (2012-2013)
Area of Support Funding
Category
Expenditures
(2012 ECD)
% of Total
Expenditures
(2012)
Expenditures
(2013 ECD)
% of Total
Expenditures
(2013)
Care & Treatment
Public $ 92,400.00 2% $ 92,400.00 2%
Private $ 80,000.00 2% $ 80,000.00 2%
International
Donors
$ 452,907.72 11% $ 230,088.12 5%
Care & Treatment Sub-Total $ 625,307.72 16% $ 402,488.12 9%
Prevention
Public $ - 0% $ 12,000.00 0%
Private $ - 0% $
-
0%
International
Donors
$ 1,123,121.82 28% $1,587,837.00 37%
Prevention Sub-Total $ 1,123,121.82 28% $1,599,837.00 37%
OVC
Public $ 540,000.00 14% $ 540,000.00 13%
Private $ - 0% $
-
0%
International
Donors
$ - 0% $
-
0%
OVC Sub-Total $ 540,000.00 14% $ 540,000.00 13%
25. 21
Area of Support Funding
Category
Expenditures
(2012 ECD)
% of Total
Expenditures
(2012)
Expenditures
(2013 ECD)
% of Total
Expenditures
(2013)
Health Systems
Strengthening
Public $ 919,253.00 23% $1,004,028.00 24%
Private $ - 0% $
-
0%
International
Donors
$ 631,962.35 16% $ 553,389.10 13%
HSS Sub-Total $ 1,551,215.35 39% $1,557,416.00 36%
Social Protection &
Social Services
Public $ 110,000.00 3% $ 110,000.00 3%
Private $ - 0% $
-
0%
International
Donors
$ - 0% $
-
0%
Social Protection Sub-Total $ 110,000.00 3% $ 110,000.00 3%
Enabling Environment
Public $ - 0% $
-
0%
Private $ - 0% $
-
0%
International
Donors
$ 10,209.00 0% $ 57,400.00 1%
Enabling Environment Sub-Total $ 10,209.00 0% $ 57,400.00 1%
Total Expenditures $ 3,959,853.89 $4,267,141.12
**Source: Global AIDS Response Progress Report, SVG, 2014
**2.7 EC$ = 1 US$
Table 2 presents total HIV/AIDS expenditures in St. Vincent and the Grenadines, broken down by
funding source for 2012 and 2013. In most cases, due to data limitations, the table could not
disaggregate HIV/AIDS spending by organization or institution. Key public ministries that are included in
the below government funding sources include the Ministry of Health, Wellness, and the Environment,
Ministry of Social Welfare, Ministry of Education, and Ministry of Labor. These departments accounted
for 42% and 41% of total HIV/AIDS expenditures in 2012 and 2013, respectively (UNGASS, 2014).
Among donors, data on HIV/AIDS funding was available for Global Fund and PEPFAR; however, the
remaining institutions were grouped as all other multilateral and bilateral donors. In 2012 and 2013, the
Global Fund accounted for 6% of total HIV/AIDS expenditures, PEPFAR between 17-18%, and the
remaining donor institutions identified as multilateral and bilateral donors at 32-34%. Of these three
26. 22
donor groups, only the remaining multilateral and bilateral organizations increased total HIV/AIDS
funding between 2012 and 2013. Finally, private sector spending accounted for only 2% of total, direct
and indirect expenditures in both 2012 and 2013.
Table 3: HIV/AIDS Expenditures by Funding Source (2012-2013)
Funding Source Category Expenditures
(2012 ECD)
% of Total
Expenditures
(2012)
Expenditures
(2013 ECD)
% of Total
Expenditures
(2013)
Government $ 1,661,653.00 42% $ 1,758,428.00 41%
Donors
Global Fund $ 249,140.22 6% $ 249,140.22 6%
PEPFAR $ 715,667.00 18% $ 715,667.00 17%
Multilateral/Bilateral Donors $ 1,252,393.67 32% $ 1,463,908.00 34%
Private sector $ 81,000.00 2% $ 80,000.00 2%
Total Expenditures $ 3,959,853.89 $ 4,267,143.22
**Source: Global AIDS Response Progress Report, SVG, 2014
**2.7 EC$ = 1 US$
3.4 Vulnerability to cuts in external funding
Table 4 portrays a hypothetical financing landscape for HIV/AIDS from 2012 through 2018 where
current and expected funding is presented by funding source. Once again, in most cases data was also
not available to break down spending by area of support or by specific organizations/institutions. Data
from 2015 to 2018 are estimates based on historical spending and interviews with individuals within
these institutions. While it is impossible to predict precise future HIV/AIDS spending across all
institutions, the aim of Table 4 is to assess how vulnerable each organization is to funding cuts and what
additional resources will be needed to sustain or expand St. Vincent and the Grenadines’ HIV/AIDS
response.
Among public sector institutions, only the Ministry of Health, Wellness, and the Environment is included
in Table 4. There are two reasons why no other ministry has been included. First, the Ministry of Social
Welfare, Ministry of Labor, and Ministry of Education do not earmark funds for HIV/AIDS so annual
spending is both small and volatile. Second, funding from these sources primarily targets indirect
HIV/AIDS spending, such as OVCs, and is therefore less pertinent to the direct care, treatment, and
prevention of St. Vincent and the Grenadines’ HIV/AIDS response. While future spending by the
Ministry of Health may decline and is predicated on funding from the Ministry of Finance, Table 4
optimistically predicts that its funding will increase from 2013 through 2018. From 2013 to 2014, the
additional 51,967 ECD stems from the share of ARV costs borne by the MoHWE; from 2015 through
2018, Table 4 predicts that government spending will increase at 1% per annum.
Among donors, future HIV/AIDS funding is broken down by Global Fund, PEPFAR, and all remaining
multilateral and bilateral organizations. Table 4 indicates that the current Round 9 Global Fund funding
27. 23
will decline significantly through 2017, after which funding will be zero (given that the current application
for funding is not yet secured). For 2014-2016, the Global Fund has indicated to OECS countries that it
will finance anti-retroviral therapy medications for HIV/AIDS treatment, and thus spending on these
drugs represents the below figures for 2014-2016.
Future PEPFAR funding is broken down by direct and indirect HIV/AIDS spending; using data from the
National Health Account in St. Kitts and Nevis as a proxy for St. Vincent and the Grenadines, PEPFAR
allocates roughly 25% of total funding to care, treatment, and prevention, while the remaining 75% is
spent on technical assistance, health system strengthening, and other indirect sources. For both direct
and indirect spending, PEPFAR funding is expected to increase slightly through 2014 and decline
thereafter. PEPFAR’s total spending is estimated to be $168,150 ECD in 2015 and declining thereafter.
KfW, a bilateral donor who funds PSI in the Caribbean, contributed towards direct HIV/AIDS spending –
specifically prevention activities such as condom distribution, HIV testing and counseling and STI services
through Planned Parenthood, and public education campaigns. Their funding for HIV/AIDS is expected to
decline from $115,441.87 ECD in 2013 to $23,601.56 in 2015, with no earmarked funding thereafter.
Table 4 reflects sources of funding from 2013 to 2018. Funding from SVG’s private sector and remaining
multilateral and bilateral organizations is unstable and could likely decline given the current donor
climate in the Region. Given information provided by donors, donor patterns in the Region, we have
made the assumptions below regarding future donor funding. Private sector allocations have been kept
constant given that these collaborators have expressed interest in continuing current work place
prevention programs and testing days. Per the row for total expenditures, the estimated gap between
current (2013) and future (2018) HIV/AIDS spending would be $767,491 ECD.
28. 24
Table 4: Estimated Resource Availability for HIV and AIDS Programming by Funding Source (2012-
2018)
Funding Source
Category
Expenditures
(2012 ECD)
Expenditures
(2013 ECD)
Expenditures
(2014 ECD)
Projected
Expenditures
(2015 ECD)
Projected
Expenditures
(2016 ECD)
Projecte
Expenditu
(2017 EC
Government
Ministry of Health $1,121,653.00 $1,218,428.00 $1,270,395.00 $1,283,098.95 $1,295,929.94 $1,308,8
International donors
Global Fund $123,417.22 $103,388.00 $86,946.00 $56,926.00 $50,094.00
PEPFAR (Direct*
Programming)
$483,050.22 $483,050.22 $782,936.00 $168,750.00 $135,000.00 $101,2
KfW (PSI Direct*
Programming)
$311,893.00 $115,441.87 $94,406.25 $23,601.56
Multilateral/Bilateral
Donors
$35,784.78 $131,856.24
Private sector $81,000.00 $80,000.00 $80,000.00 $80,000.00 $80,000.00 $80,0
Total
Expenditures
$2,156,798.22 $2,132,164.33 $2,314,683.25 $1,612,376.51 $1,561,023.94 $1,490,1
Source: Global AIDS Response Progress Report, SVG, 2014
2.7 EC$ = 1 US$
*Note:: For PEPFAR and KfW estimations, support for technical assistance has not been included.
3.5 Resource gap analysis
The resource gap analysis presents the financial gap (surplus, deficit, or budget neutral) between the cost
of each scenario and the expected resources available. In Table 5, resource needs from each of the
three scenarios are presented along with the projected resources available in St. Vincent and the
Grenadines for its HIV and AIDS program through 2018/2020. The difference between the resource
needs and the available resources is projected in Figure 9 and represents the funding gap that will exist
and must be filled if St. Vincent and the Grenadines intends to achieve each scenario’s coverage goals.
29. 25
Beginning in 2015, all scenarios present a significant deficit, which is most significant with the 90/90/90
scenario. The gap per annum for all scenarios is illustrated in Table 5, which gradually increases to over
2 million ECD for the maintenance and reduce prevention scenarios and over 7 million ECD for the
90/90/90 scenario by 2020.
Table 5: Scenarios’ costs and resource availability from 2015-20, in millions of ECD.
2015 2016 2017 2018 2019 2020
Cost: Reduce prevention 3.47 3.54 3.60 3.65 3.70 3.74
Cost: Maintenance 4.04 4.10 4.15 4.19 4.23 4.26
Cost: 90/90/90 4.16 4.96 5.84 6.78 7.77 8.81
Resources available 1.90 1.79 1.66 1.58 1.42 1.43
Resource gap: Reduce
prevention 1.57 1.75 1.93 2.06 2.28 2.31
Resource gap: Maintenance 2.14 2.31 2.49 2.61 2.81 2.83
Resource gap: 90/90/90 2.27 3.17 4.18 5.19 6.35 7.39
Figure 9: Scenarios’ costs and resource availability from 2014-20, in millions of ECD.
$-
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
$8.00
$9.00
$10.00
2014 2015 2016 2017 2018 2019 2020
Scenario Costs and Resources Available
ECD Millions, 2014-2020
Reduce Prevention Maintenance 90-90-90 by 2020 Estimated Resources Available
30. 26
Data presented in Figure 9 shows the resource gap by scenario and year from 2014 to 2020. Given the
projected availability of resources for HIV and AIDS programming that remains slightly under two
million ECD, the resource gap for all scenarios is significant beginning in 2015. As per Table 5, the
maintenance and reduce prevention scenarios require an additional 1-2ECD per annum while the 90-90-
90 scenario will begin requiring 2 million ECD and by 2020 require an additional 7.39 million ECD.
4. CONCLUSIONS
This report aimed to assist the government of St. Vincent and the Grenadines by model and evaluating
three future scenarios for its HIV/AIDS program. Results from the Goals model indicate that while each
of the scenarios offer markedly different strategies for addressing St. Vincent and the Grenadines’
HIV/AIDS epidemic and thus result in different impacts, all three will require additional resources
beyond what is expected to be available. Regardless of the scenario chosen, policymakers will be faced
with considerable tradeoffs and must ultimately prioritize scare resources.
The prevention scenario, which estimates a dramatic decline in prevention spending for HIV/AIDS,
would result in the largest rise in HIV infections and AIDS deaths. While the cost of this scenario is the
lowest of the three scenarios, the resource gap is still significant, requiring an additional 2.31 million
ECD by 2020. The maintenance scenario, reduced funding is offset by new funding sources, and thus
SVG’s HIV/AIDS program would “maintain” its current trajectory. HIV infections and AIDS deaths
would rise slightly through 2020, but the resource gap rises to $2.83 million EC. Finally, the ambitious
90-90-90 scenario (90% of HIV positive individuals aware of their status; 90% of ART eligible individuals
on ART; and 90% of people on treatment have suppressed viral loads) would see a significant decline in
HIV infections and AIDS deaths through 2020, but the resource gap of achieving these targets is a
staggering $7.39 million EC in 2020.
Results from the resource availability analysis predict that domestic funding for HIV/AIDs is likely to
remain constant or, optimistically, experience a marginal rise. Donor funding from PEPFAR and the
Global Fund is expected to decline, while other sources of funding (e.g. other donors and the private
sector) are not earmarked and thus highly volatile. This outlook suggests that maintaining existing
spending levels on HIV/AIDS will be a significant challenge for St. Vincent and the Grenadines. Among
the options presented, the prevention scenario is most likely to occur without additional sources of
domestic or donor funding and SVG could plan for and potentially achieve the “maintenance” scenario
through 2020.
The Caribbean Region has reiterated its commitment to scaling up its HIV/AIDS program to a 90/90/90
scenario by 2020. Making this a reality in each of the countries, including St. Vincent and the Grenadines,
presents a significant challenge. Achieving such an ambitious goal will require (a) substantially greater
political commitment to HIV/AIDS and additional domestic resources; (b) prioritizing scare resources;
(c) improvements in the efficiency of existing HIV/AIDS spending.
31. 27
While it is impossible to predict how domestic resources will be allocated in future years, policymakers
can begin by considering options for prioritizing resources and improving efficiency. This includes (i)
better integrating HIV/AIDS services into the country’s existing health system; (ii) reducing
fragmentation, reducing duplication, and improving coordination of existing HIV/AIDS services; (iii)
reducing the cost of HIV/AIDS services (e.g. via changes to provider reimbursements, drug
procurement, or supply chain management); (iv) prioritizing key populations and HIV/AIDS
interventions. These are a sample of options that were addressed during prior validation meetings with
public and private sector stakeholders in St. Vincent and the Grenadines. As individuals found during
those discussions, there are no easy choices. They require sincere thought, collaboration and consensus
from a diverse group of individuals. However, St. Vincent and the Grenadines must consider the
tradeoffs and make difficult decisions on these topics if it hopes to achieve the 90-90-90 scenario by
2020.
32.
33. 29
ANNEX A: INPUTS TO THE GOALS & RESOURCE
NEEDS MODELS
Distribution of the Population by Risk Group Value Source
Percentage of males
Not sexually active (Never had sex) 14.70% 2011 St. Kitts KAPB Table 99. Value for St. Kitts. Not available for St. Vincent.
Low risk heterosexual (One partner in the last year) 51.74% remaindered
Medium risk heterosexual (more than one partner in last year) 23.60% 2011 St. Kitts KAPB Appendix I page 163. Not available for St. Vincent.
High risk heterosexual (Client of sex worker) 7.80%
Balanced with female high risk percentage and number of partners per year.
Value for St. Kitts. Not available for St. Vincent.
MSM 2.16%
2012 PEPFAR report. Estimated number of MSM in population 15-49, divided by
male population 15-49 in 2012.
Percentage of females
Not sexually active (Never had sex) 9.00% 2011 St. Kitts KAPB Table 99. Value for St. Kitts. Not available for St. Vincent.
Low risk heterosexual (One partner in the last year) 64.80% remaindered
Medium risk heterosexual (more than one partner in last year) 23.60% Assumed to be similar to medium risk percentage among males.
High risk heterosexual (Sex worker) 2.60% 2011 Dominica KAPB page 108. Not available for St. Vincent.
Percentage of IDU sharing needles
Condom use in last sex act (Latest available, plus earlier years if
available)
Low risk 38.0% 2011 St. Kitts KAPB Table 126. Not available for St. Vincent.
Medium risk 62.5% 2011 St. Kitts KAPB Appendix I. Not available for St. Vincent.
High risk 62.5% Assumed to be similar to condom use in medium risk category.
MSM 73.3%
Men Who Have Sex with Men Behavioural and HIV Seroprevalence PILOT Study
conducted in St. Vincent & the Grenadines, 2010.
Number of partners per year
Males
34. 30
Distribution of the Population by Risk Group Value Source
Low risk 1 By definition.
Medium risk 4.0 Not available; standard value.
High risk 30 Required to balance number of high risk sex acts.
MSM 6.3 Required to balance number of high risk sex acts.
Females
Low risk 1 By definition.
Medium risk 4.0 Not available; standard value.
High risk 100 Required to balance number of high risk sex acts.
Sex acts per partner
Low risk 80 Standard international value.
Medium risk 20 Not available; standard value.
High risk 3 Not available; standard value.
MSM 14 Not available; standard value.
Age at first sex
Males 16.0 Value for Dominica. Not available for St. Vincent.
Females 15.0 Value for Dominica. Not available for St. Vincent.
Percent married or in union
Males
Low risk 100.0% By definition all are married/in union
Medium risk 27.0% Value for Dominica. Not available for St. Vincent.
High risk 27.0% Value for Dominica. Not available for St. Vincent.
IDU 0.0%
MSM 27.0% Value for Dominica. Not available for St. Vincent.
Females
Low risk 100.0% By definition all are married/in union
Medium risk 27.0% Value for Dominica. Not available for St. Vincent.
High risk 27.0% Value for Dominica. Not available for St. Vincent.
IDU 0.0%
35. 31
Distribution of the Population by Risk Group Value Source
STI prevalence (Latest available, plus earlier years if available)
Males
Low risk 3% Half of female estimate.
Medium risk 10% Not available; standard value.
High risk 15% Not available; standard value.
MSM 17%
Men Who Have Sex with Men Behavioural and HIV Seroprevalence PILOT Study
conducted in St. Vincent & the Grenadines, 2010.
Females
Low risk 6%
2011 St. Kitts KAPB page 161. Percentage with genital discharge in past 12
months.
Medium risk 15% Not available; standard value.
High risk 30% Not available; standard value.
Coverage of behavior change interventions
General population
Community mobilization: reached by intervention per year (%) 10.0% NAP Coordinator estimate
Mass media: reached by campaigns per year (%) 50.0% NAP Coordinator estimate
VCT: Adult population receiving VCT each year (%) 9.0% 2014 UNGASS report. Number testing during 2012-13, divided by population.
Condom coverage (%) 62.5% Equal to medium risk use
Primary students with teachers trained in AIDS (%) 90.0% Interview MOH-Reference of past UNGASS reports
Secondary students with teachers trained in AIDS (%) 40.0% Interview MOH-Reference of coverage of 4 levels, 1 or 2 levels covered
Most-at-risk populations
Female sex workers (%) 53.4%
McLean et al., "The Cost of HIV Prevention Interventions for Key Populations in
the Eastern Caribbean and Barbados". HPP Report 2014.
MSM outreach (%) 61.9%
McLean et al., "The Cost of HIV Prevention Interventions for Key Populations in
the Eastern Caribbean and Barbados". HPP Report 2014.
Male circumcision: Percent of males 15-49 circumcised 20%
Men Who Have Sex with Men Behavioural and HIV Seroprevalence PILOT Study
conducted in St. Vincent & the Grenadines, 2010. Ministry of Health and
Wellness.
Treatment
(CD4 count threshold for eligibility by year) 350
36. 32
Distribution of the Population by Risk Group Value Source
Percent of adult males in need receiving ART by year 44.3%
Number on ART in 2012 from 2014 UNGASS report divided by estimated
number eligible.
Percent of adult females in need receiving ART by year 40.3%
Number on ART in 2012 from 2014 UNGASS report divided by estimated
number eligible.
Community mobilization cost per person reached $ 3.29
LAC regional average; Financial Resources Required to Achieve National Goals
for HIV Prevention, Treatment, Care and Support, 2014
Cost per VCT client $ 30.00
LAC regional average; Financial Resources Required to Achieve National Goals
for HIV Prevention, Treatment, Care and Support, 2014
Most-at-risk populations
Cost per female sex worker reached $ 180.43
McLean et al., The Cost of HIV Prevention Interventions for Key Populations in
the Eastern Caribbean and Barbados. HPP Report 2014.
Cost per MSM targeted $ 180.43
McLean et al., The Cost of HIV Prevention Interventions for Key Populations in
the Eastern Caribbean and Barbados. HPP Report 2014.
Medical Services
Cost per STI treated in clinics $ 65.00
Global average; Financial Resources Required to Achieve National Goals for HIV
Prevention, Treatment, Care and Support, 2014
Cost of screening a unit of blood for HIV $ 18.57
LAC regional average; Financial Resources Required to Achieve National Goals
for HIV Prevention, Treatment, Care and Support, 2014
PMTCT
HIV testing (per test): PCR for infant after birth $ 62.00 Default
ARVs (cost per person per day): Triple treatment (AZT+3TC+NVP/EVF) $ 1.66
SAS regional average; Financial Resources Required to Achieve National Goals
for HIV Prevention, Treatment, Care and Support, 2014.
ARVs (cost per person per day): Triple prophylaxis $ 1.66
SAS regional average; Financial Resources Required to Achieve National Goals
for HIV Prevention, Treatment, Care and Support, 2014.
Treatment
Adults (cost per patient per year): First line ART drugs $ 174.38 OECS data point from GPRM: TDF/3TC/EFV
Adults (cost per patient per year): Second line ART drugs $ 518.80 OECS data point from GPRM: TDF/FTC/LPV/ritonavir
Adults (cost per patient per year): Lab costs for ART treatment $ 216.00
Routh, Subrata, Josef Tayag. September 2012. Costing of Primary Health Care
and HIV/AIDS Services in Antigua and Barbuda: A Preliminary Report. Bethesda,
MD: Health Systems 20/20 project, Abt Associates Inc.
Children (cost per patient per year): ARV drugs $ 174.38 OECS data point from Global Price Reporting Mechanism for TDF/3TC/EFV
Children (cost per patient per year): Lab costs for ART treatment $ 216.00
Routh, Subrata, Josef Tayag. September 2012. Costing of Primary Health Care
and HIV/AIDS Services in Antigua and Barbuda: A Preliminary Report. Bethesda,
MD: Health Systems 20/20 project, Abt Associates Inc.
37. 33
Distribution of the Population by Risk Group Value Source
Service delivery costs: Cost per in-patient day $ 332.92
Routh, Subrata, Josef Tayag. September 2012. Costing of Primary Health Care
and HIV/AIDS Services in Antigua and Barbuda: A Preliminary Report. Bethesda,
MD: Health Systems 20/20 project, Abt Associates Inc.
Service delivery costs: Cost per out-patient vist $ 233.70
Routh, Subrata, Josef Tayag. September 2012. Costing of Primary Health Care
and HIV/AIDS Services in Antigua and Barbuda: A Preliminary Report. Bethesda,
MD: Health Systems 20/20 project, Abt Associates Inc.
Service delivery requirements (per patient per year): ART out-patient visits $ 1.00 Annual cost
Service delivery requirements (per patient per year): OI treatment in-
patient days
$ 1.00 Annual cost
Migration from first to second line (% per year) 15% 2014 UNGASS report, page 16
Policy and Program Support
Enabling environment 2.0%
Social Protection and Social Services 3.8%
Systems Strengthening Program Coordination 28.0%
38.
39. 35
ANNEX B: EPIDEMIOLOGICAL
PARAMETERS
Parameter Value Source
Transmission of HIV per act (female to male) 0.0019 Baggeley et ali
., Gray et al.
Multiplier on transmission per act for
Male to female 1.0 Galvin and Cohenii
, 2.2-11.3
Presence of STI 5,5 Powers et a.liii
. 5.1-8.2
MSM contacts 2.6 Vittinghoff et aliv
.
Relative infectiousness by stage of infection
Primary infection 9 –40 Boily et a.lv
. 9.17 (4.47-18.81)
Asymptomatic 1 Pinkertonvi
Symptomatic 7 Boily et al6
. 7.27 (4.45-11.88)
On ART 0.04 – 0.08 Cohen et al.vii
Efficacy in reducing HIV transmission Weller and Davisviii
Condom use
0.8 Weller and Davisix
Auvert et alx
, Gray et al.
(2007)xi
, Bailey et al.xii
Male circumcision 0.6 Grant et al.xiii
Partners PrEP Study
PrEP 0.55 – 0.73 Partners PrEP Study
Microbicide 0.6 Abdool Karim et al.xiv
40. i
Baggaley RF, Fraser C. Modelling sexual transmission of HIV: testing the assumptions, validating the predictions.
Curr Opin HIV AIDS. 2010; 5(4): 269-76.
ii
Galvin and Cohen, "The Role of Sexually Transmitted Diseases in HIV Transmission" Nature Reviews
Microbiology Volume 3, January 2004, pps. 33-42.
iii
Powers KA, Poole C, Pettifor AE, Cohen MS Rethinking the heterosexual infectivity of HIV-1: a systematic
review and meta-analysis The Lancet Published on line August 5, 2008 DOI:10.1016/S1273-3099(08)70156-7.
iv
Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-Contact Risk of Human
Immunodeficiency Virus Transmission between Male Sexual Partners Am J Epidemiol (1999)150:3;306-31 suggests
0.0016/0.0011.
v
Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M. Heterosexual risk of HIV-1 infection per
sexual act: systematic review and meta-analysis of observational studies Lancet Infect Dis 2009; 9: 118-29.
vi
Pinkerton SD. Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS Behav. 2008; 12(5):
677-84.
vii
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1
Infection with Early Antriretroviral Therapy N Engl J Med 2011; 10.1056/NEJMoa1105243.
viii
Weller S, Davis, K. Condom effectiveness in reducing heterosexual HIV transmission (Cochrane Review). In:
The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
ix
Weller S, Davis, K. Condom effectiveness in reducing heterosexual HIV transmission (Cochrane Review). In: The
Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
x
Auvert B, Puren A, Taljaard D, Lagarde E, JoëlleTambekou-Sobngwi, RémiSitta. The impact of male circumcision
on the female-to-male transmission of HIV : Results of the intervention trial : ANRS 1265. IAS 2005: INSERM,
France; 2005.
xi
Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in
young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562): 643-56.
xii
Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in
young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562): 643-56.
xiii
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L. Preexposure Chemoprophylaxis for HIV
Prevention in Men Who Have Sex with Men New Engl J Med 2010, 10.1056/NEJMoa1011205.
xiv
Karim QA, Karim SSA, Frohlich J, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and Safety of
Tenofovir Gel, an Antoretroviral Microbicide, for the Prevention of HIV Infection in Women. Science 329; 1168-
1174 (September 2010).